Nir Y. Uriel

Nir Y. Uriel's AcademicInfluence.com Rankings

Nir Y. Uriel

Philosophy

#6731

World Rank

#9821

Historical Rank

Logic

#3852

World Rank

#5072

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Nir Y. Uriel's Degrees

Doctorate Medicine Tel Aviv University
Masters Public Health Columbia University

Why Is Nir Y. Uriel Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nir Y. Uriel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Post-acute COVID-19 syndrome (2021) (2173)
Extrapulmonary manifestations of COVID-19 (2020) (1998)
COVID-19 and Cardiovascular Disease (2020) (1272)
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter (2020) (652)
A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report (2019) (582)
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure (2017) (564)
Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. (2010) (535)
Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure (2018) (516)
The Variety of Cardiovascular Presentations of COVID-19 (2020) (437)
Hemodynamics of Mechanical Circulatory Support. (2015) (363)
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease (2020) (330)
Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study. (2012) (311)
Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. (2010) (218)
PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study. (2017) (211)
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research (2020) (194)
Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. (2013) (176)
Hemodynamic Ramp Tests in Patients With Left Ventricular Assist Devices. (2016) (174)
Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure (2017) (164)
HVAD: The ENDURANCE Supplemental Trial. (2018) (163)
Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. (2014) (162)
Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome (2012) (159)
Prevalence, Significance, and Management of Aortic Insufficiency in Continuous Flow Left Ventricular Assist Device Recipients (2014) (158)
Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? (2013) (157)
Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019. (2020) (155)
Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. (2014) (147)
Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention (2016) (143)
Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. (2012) (120)
Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. (2014) (114)
Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding (2016) (113)
Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. (2016) (110)
Validity and Reliability of a Novel Slow Cuff-Deflation System for Noninvasive Blood Pressure Monitoring in Patients With Continuous-Flow Left Ventricular Assist Device (2013) (107)
An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection. (2017) (102)
Mechanical Unloading in Heart Failure. (2018) (100)
Reverse remodelling and myocardial recovery in heart failure (2018) (99)
The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. (2017) (93)
Serial echocardiography using tissue Doppler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery. (2013) (90)
Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the HeartMate 3 Versus the HeartMate II Cardiac Pump (2019) (86)
Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support. (2020) (86)
Bridge-to-Decision Therapy With a Continuous-Flow External Ventricular Assist Device in Refractory Cardiogenic Shock of Various Causes (2014) (84)
Left Ventricular Assist Devices for Lifelong Support. (2017) (81)
Indications for and Findings on Transthoracic Echocardiography in COVID-19 (2020) (75)
Approach to Acute Cardiovascular Complications in COVID-19 Infection. (2020) (74)
Heart transplantation in human immunodeficiency virus-positive patients. (2009) (74)
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent (2020) (73)
Identification and Management of Pump Thrombus in the HeartWare Left Ventricular Assist Device System: A Novel Approach Using Log File Analysis. (2015) (72)
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19 (2021) (70)
Use of a percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure. (2018) (67)
Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices (2011) (66)
Early post-operative ventricular arrhythmias in patients with continuous-flow left ventricular assist devices. (2015) (64)
Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19 (2020) (62)
Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility‐related adverse events (2019) (62)
Left Ventricular Decompression During Speed Optimization Ramps in Patients Supported by Continuous-Flow Left Ventricular Assist Devices: Device-Specific Performance Characteristics and Impact on Diagnostic Algorithms. (2015) (61)
The Subclavian Intraaortic Balloon Pump: A Compelling Bridge Device for Advanced Heart Failure. (2015) (59)
Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. (2017) (56)
Continuous-flow left ventricular assist device exchange: clinical outcomes. (2014) (55)
Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections. (2016) (55)
Accurate Quantification Methods for Aortic Insufficiency Severity in Patients With LVAD: Role of Diastolic Flow Acceleration and Systolic-to-Diastolic Peak Velocity Ratio of Outflow Cannula. (2015) (55)
Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates (2019) (54)
Impact of Hemodynamic Ramp Test-Guided HVAD Speed and Medication Adjustments on Clinical Outcomes: The RAMP-IT-UP Multicenter Study (2019) (53)
Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support. (2015) (53)
Acute heart failure associated with high admission blood pressure — A distinct vascular disorder? (2007) (53)
Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation. (2013) (52)
Clinical hemodynamic evaluation of patients implanted with a fully magnetically levitated left ventricular assist device (HeartMate 3). (2017) (51)
Mitral Valve Repair at the Time of Continuous-Flow Left Ventricular Assist Device Implantation Confers Meaningful Decrement in Pulmonary Vascular Resistance (2013) (49)
Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation (2017) (48)
3D Morphological Changes in LV and RV During LVAD Ramp Studies. (2017) (48)
Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation. (2013) (48)
Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial. (2019) (47)
Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study: Randomized Controlled Trial of a Magnetically Levitated Cardiac Pump in Advanced Heart Failure (2018) (46)
Primary results of long‐term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants (2021) (45)
Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices. (2018) (45)
The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19 (2020) (44)
Acute Mechanical Circulatory Support for Fulminant Myocarditis Complicated by Cardiogenic Shock (2014) (43)
Human immunodeficiency virus infection and left ventricular assist devices: a case series. (2011) (43)
Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device (2018) (43)
A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial. (2018) (42)
Twelve Hours of Sustained Ventricular Fibrillation Supported by a Continuous‐Flow Left Ventricular Assist Device (2012) (42)
Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death (2016) (42)
Long-Term Survival in Patients Receiving a Continuous-Flow Left Ventricular Assist Device. (2017) (41)
Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: Results from the United Network for Organ Sharing database. (2014) (41)
Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support. (2015) (41)
Relationship Between Noninvasive Assessment of Lung Fluid Volume and Invasively Measured Cardiac Hemodynamics (2018) (41)
Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study (2020) (40)
Extracorporeal cardiopulmonary resuscitation in adults: evidence and implications (2021) (39)
Timing of Temporary Right Ventricular Assist Device Insertion for Severe Right Heart Failure After Left Ventricular Assist Device Implantation (2013) (38)
Long-term outcome of patients on continuous-flow left ventricular assist device support. (2014) (38)
Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure. (2011) (37)
Early worsening heart failure in patients admitted with acute heart failure – a new outcome measure associated with long‐term prognosis? (2009) (37)
Advanced heart failure in patients infected with human immunodeficiency virus: is there equal access to care? (2014) (37)
Novel echocardiographic parameters of aortic insufficiency in continuous-flow left ventricular assist devices and clinical outcome. (2016) (37)
Atrial Arrhythmias and Electroanatomical Remodeling in Patients With Left Ventricular Assist Devices (2017) (37)
Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial. (2020) (36)
Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous-flow left ventricular assist devices. (2014) (35)
Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic (2020) (35)
Cardiovascular surgery in Jehovah's Witness patients: The role of preoperative optimization. (2015) (35)
Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis (2012) (35)
The Hemodynamic Effects of Aortic Insufficiency in Patients Supported With Continuous-Flow Left Ventricular Assist Devices. (2017) (34)
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score. (2014) (34)
Catheter Ablation for Ventricular Tachyarrhythmias in Patients Supported by Continuous-Flow Left Ventricular Assist Devices (2014) (34)
Multicenter Evaluation of Octreotide as Secondary Prophylaxis in Patients With Left Ventricular Assist Devices and Gastrointestinal Bleeding (2017) (34)
Clinical implications of hemodynamic assessment during left ventricular assist device therapy. (2017) (34)
Device Exchange in HeartMate II Recipients: Long-Term Outcomes and Risk of Thrombosis Recurrence (2015) (32)
Clinical and cardiac characteristics of COVID‐19 mortalities in a diverse New York City Cohort (2020) (32)
Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm Survival. (2017) (32)
Mediastinal radiation and adverse outcomes after heart transplantation. (2010) (32)
Hyponatraemia in acute heart failure is a marker of increased mortality but not when associated with hyperglycaemia (2008) (31)
A successful pregnancy during mechanical circulatory device support. (2011) (31)
HVAD Waveform Analysis as a Noninvasive Marker of Pulmonary Capillary Wedge Pressure: A First Step Toward the Development of a Smart Left Ventricular Assist Device Pump (2017) (29)
Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic (2021) (29)
Echocardiographic ejection fraction in patients with acute heart failure: correlations with hemodynamic, clinical, and neurohormonal measures and short‐term outcome (2005) (29)
MOLECULAR MECHANISM OF the association between atrial fibrillation and heart failure inCLUDEs Energy METABOLIC DYSREGULATION DUE to MITOCHONDRIAL DYSFUNCTION. (2019) (29)
Higher rate of comorbidities after cardiac retransplantation contributes to decreased survival. (2009) (29)
Aortic valve procedures at the time of ventricular assist device placement. (2011) (29)
The first-in-human experience with a minimally invasive, ambulatory, counterpulsation heart assist system for advanced congestive heart failure. (2018) (29)
Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device. (2018) (28)
Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30‐Day Mortality in COVID‐19 (2020) (28)
Preoperative Assessment of High-Risk Candidates to Predict Survival After Heart Transplantation (2013) (28)
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. (2022) (27)
Hypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular assist device support (2015) (26)
Cannula and Pump Positions Are Associated With Left Ventricular Unloading and Clinical Outcome in Patients With HeartWare Left Ventricular Assist Device. (2017) (26)
Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study. (2020) (25)
Discordance Between Clinical Assessment And Invasive Hemodynamics In Patients With Advanced Heart Failure. (2020) (25)
Therapeutic Strategy for Gastrointestinal Bleeding in Patients With Left Ventricular Assist Device. (2018) (25)
The CentriMag ventricular assist device in acute heart failure refractory to medical management. (2012) (25)
ECMO as a Bridge to Left Ventricular Assist Device or Heart Transplantation. (2021) (25)
Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. (2018) (25)
Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. (2020) (24)
New Challenges in the Treatment of Patients With Left Ventricular Support: LVAD Thrombosis (2016) (24)
Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo‐controlled, non‐inferiority ARIES HM3 trial (2021) (24)
Left ventricular assist device-induced reverse remodeling: it’s not just about myocardial recovery (2017) (24)
Value of Serial Echo‐Guided Ramp Studies in a Patient with Suspicion of Device Thrombosis after Left Ventricular Assist Device Implantation (2014) (23)
Speckle Tracking Imaging in Acute Inflammatory Pericardial Diseases (2011) (23)
Predictors of mortality after short-term ventricular assist device placement. (2011) (22)
Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure: DRI2P2S. (2020) (22)
Reverse Remodeling With Left Ventricular Assist Devices. (2021) (22)
The daily incidence of acute heart failure is correlated with low minimal night temperature: cold immersion pulmonary edema revisited? (2006) (22)
Association of Inflow Cannula Position with Left Ventricular Unloading and Clinical Outcomes in Patients with HeartMate II Left Ventricular Assist Device (2019) (22)
Sinus Rhythm Restoration after Atrial Fibrillation: The Clinical Value of N‐Terminal Pro‐BNP Measurements (2008) (21)
Patterns of leukocyte counts on admissions for acute heart failure--presentation and outcome--results from a community based registry. (2011) (20)
Advanced cardiovascular life support algorithm for the management of the hospitalized unresponsive patient on continuous flow left ventricular assist device support outside the intensive care unit (2016) (20)
Peak exercise capacity is a poor indicator of functional capacity for patients supported by a continuous-flow left ventricular assist device. (2014) (20)
Predictors of survival following trans‐catheter aortic valve closure for left ventricular assist device associated aortic insufficiency (2016) (19)
Psychosocial Risk and Its Association With Outcomes in Continuous-Flow Left Ventricular Assist Device Patients (2020) (18)
Increased Risk of Bleeding in Left Ventricular Assist Device Patients Treated with Enoxaparin as Bridge to Therapeutic International Normalized Ratio (2017) (18)
Effect of &bgr;-Blocker Cessation on Chronotropic Incompetence and Exercise Tolerance in Patients With Advanced Heart Failure (2012) (17)
Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition (2020) (17)
Cardiogenic shock in a young female with multiple sclerosis. (2006) (17)
Prevalence and timing of bend relief disconnection in patients supported by the late version HeartMate II left ventricular assist device. (2013) (16)
Changes in pulmonary artery pressure before and after left ventricular assist device implantation in patients utilizing remote haemodynamic monitoring (2018) (16)
Myocardial infarction after left ventricular assist device implantation: clinical course, role of aortic root thrombus, and outcomes. (2014) (16)
Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure (2020) (16)
Transition of a Large Tertiary Heart Failure Program in Response to the COVID-19 Pandemic (2020) (16)
Decoupling Between Diastolic Pulmonary Arterial Pressure and Pulmonary Arterial Wedge Pressure at Incremental Left Ventricular Assist Device (LVAD) Speeds Is Associated With Worse Prognosis After LVAD Implantation. (2018) (16)
Coronary stenting with MGuard: extended follow-up of first human trial. (2011) (15)
United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis (2020) (15)
Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation (2018) (15)
Primary Results of the Sensible Medical Innovations Lung Fluid Status Monitor Allows Reducing Readmission Rate of Heart Failure Patients (smile) Trial (2019) (15)
Slope calculation for the LVAD ramp test. (2013) (15)
Acquired von Willebrand disease during CentriMag support is associated with high prevalence of bleeding during support and after transition to heart replacement therapy. (2014) (15)
Effect of CYP2C9 and VKORC1 Gene Variants on Warfarin Response in Patients with Continuous-Flow Left Ventricular Assist Devices (2016) (14)
Predictors of Hemodynamic Improvement and Stabilization Following Intraaortic Balloon Pump Implantation in Patients With Advanced Heart Failure. (2018) (14)
Left Atrial Appendage Occlusion With Left Ventricular Assist Device Decreases Thromboembolic Events. (2019) (14)
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. (2021) (14)
Early intervention for lactate dehydrogenase elevation improves clinical outcomes in patients with the HeartMate II left ventricular assist device: Insights from the PREVENT study. (2018) (14)
Aortic root thrombosis in patients supported with continuous-flow left ventricular assist devices. (2018) (14)
Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devices. (2016) (14)
Sharing the care of mechanical circulatory support: collaborative efforts of patients/caregivers, shared-care sites, and left ventricular assist device implanting centers. (2015) (14)
Screening for Outflow Cannula Malfunction of Left Ventricular Assist Devices (LVADs) With the Use of Doppler Echocardiography: New LVAD-Specific Reference Values for Contemporary Devices. (2016) (14)
Heart health in the age of highly active antiretroviral therapy: a review of HIV cardiomyopathy (2018) (13)
Percutaneous Transcatheter Therapies for the Management of Left Ventricular Assist Device Complications. (2017) (13)
Invasive Right Ventricular Pressure-Volume Analysis: Basic Principles, Clinical Applications, and Practical Recommendations (2021) (13)
Short and long-term outcome of pregnant women with preexisting dilated cardiomypathy: an NTproBNP and echocardiography-guided study. (2010) (13)
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Crisis Standards of Care. (2020) (13)
Myocardial Recovery After LVAD Implantation: A Vision or Simply an Illusion? (2017) (13)
The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery (2018) (12)
Myocardial Injury in COVID-19 Patients (2020) (12)
Use of Ventricular Assist Devices in Patients with Mitral Valve Prostheses (2011) (12)
Effect of acute β-blocker withholding on ventilatory efficiency in patients with advanced chronic heart failure. (2010) (12)
Aortic Insufficiency during HeartMate 3 Left Ventricular Assist Device Support: AI in HeartMate 3. (2020) (12)
Amiodarone Treatment Prior to Heart Transplantation Is Associated with Acute Graft Dysfunction and Early Mortality: A Propensity-Matched Comparison (2014) (12)
Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation. (2022) (12)
Increasing heart transplant donor pool by liberalization of size matching. (2019) (12)
Consequences of Retained Defibrillator and Pacemaker Leads After Heart Transplantation-An Underrecognized Problem. (2018) (11)
Impact of Cardiac Resynchronization Therapy on Left Ventricular Unloading in Patients with Implanted Left Ventricular Assist Devices (2019) (11)
Sequential Organ Failure Assessment Score at Presentation Predicts Survival in Patients Treated With Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation. (2016) (11)
Impact of Residual Valve Disease on Survival After Implantation of Left Ventricular Assist Devices. (2018) (11)
Immune checkpoint inhibitor myocarditis (2019) (11)
Correlation Between Home INR and Core Laboratory INR in Patients Supported with Continuous-Flow Left Ventricular Assist Devices (2015) (11)
Remote Cardiac Monitoring in Patients With Heart Failure: A Review. (2021) (11)
Aortic Insufficiency and Hemocompatibility-related Adverse Events in Patients with Left Ventricular Assist Devices: AI and HRAE. (2019) (11)
Incidence and Outcomes of Postoperative Atrial Fibrillation After Left Ventricular Assist Device (2018) (11)
The cardiac intensive care unit and the cardiac intensivist during the COVID-19 surge in New York City (2020) (11)
Evolution in Mechanical Circulatory Support: Are We at the Precipice of a Disruptive Innovation? (2015) (11)
Feasibility and utility of intraoperative epicardial scar characterization during left ventricular assist device implantation (2019) (11)
PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management (PREVENT) (2016) (11)
Acute myocardial infarction with spontaneous reperfusion: clinical characteristics and optimal timing for revascularization. (2007) (11)
Impact of Temporary Percutaneous Mechanical Circulatory Support Before Transplantation in the 2018 Heart Allocation System. (2021) (11)
Left Ventricular Assist Device Deactivation via Percutaneous Closure of the Outflow Graft. (2016) (10)
Mechanical circulatory support devices: methods to optimize hemodynamics during use (2017) (10)
Repeated Ramp Tests on Stable LVAD Patients Reveal Patient-Specific Hemodynamic Fingerprint (2017) (10)
Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices (2018) (10)
Management of cardiac arrest in 2005: an update. (2005) (10)
Clinico-histopathologic and single-nuclei RNA-sequencing insights into cardiac injury and microthrombi in critical COVID-19 (2021) (9)
Ventricular assist device-associated thrombus. (2011) (9)
Nitric oxide synthase inhibitors in post‐myocardial infarction cardiogenic shock—an update (2006) (9)
Frequency of Atrial Arrhythmia in Hospitalized Patients With COVID-19 (2021) (9)
Successful percutaneous trans‐catheter treatment of left ventricular assist device outflow graft stenosis with a covered stent (2015) (9)
Comparing outcomes for infiltrative and restrictive cardiomyopathies under the new heart transplant allocation system (2020) (9)
Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial. (2022) (9)
Donor‐derived cell‐free DNA is associated with cardiac allograft vasculopathy (2020) (9)
Defining a Clinically Important Change in 6-Minute Walk Distance in Patients With Heart Failure and Mitral Valve Disease. (2021) (9)
Infective endocarditis in a tertiary-care hospital in southern Israel. (1998) (9)
Cardiac Output Assessment in Patients Supported with Left Ventricular Assist Device: Discordance Between Thermodilution and Indirect Fick Cardiac Output Measurements (2017) (8)
Bridging cardiogenic shock patients with short-term ventricular support at a community hospital to long-term ventricular support at a tertiary hospital. (2012) (8)
A Multicenter Evaluation of Octreotide for Ventricular Assist Device Related Gastrointestinal Bleeding (2016) (8)
Association between "Unacceptable Condition" Expressed in Palliative Care Consultation before Left Ventricular Assist Device Implantation and Care Received at the End of Life. (2020) (8)
Echocardiographic Changes in Patients Implanted With a Fully Magnetically Levitated Left Ventricular Assist Device (Heartmate 3). (2019) (8)
Improvement in Biventricular Cardiac Function After Ambulatory Counterpulsation. (2019) (8)
Donor-Derived Cell-Free DNA is Associated with Cardiac Allograft Vasculopathy. (2020) (8)
Biventricular Pacing Versus Right Ventricular Pacing in Patients Supported With LVAD. (2021) (8)
Peripheral venous congestion causes time‐ and dose‐dependent release of endothelin‐1 in humans (2017) (8)
Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients. (2020) (8)
Increase in short-term risk of rejection in heart transplant patients receiving granulocyte colony-stimulating factor. (2018) (8)
The Role of Palliative Care in Withdrawal of Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock. (2020) (8)
Characteristics and Outcomes of Patients With a Left Ventricular Assist Device With Coronavirus Disease-19 (2020) (8)
Outflow Graft Narrowing of the Heartmate 3 Left Ventricular Assist Device: Incidence, Imaging Findings, and Outcomes (2021) (7)
Extracorporeal photopheresis and its role in heart transplant rejection: prophylaxis and treatment (2021) (7)
Invasive Hemodynamic Echocardiographic Ramp Test in the HeartAssist5 LVAD: Insights into Device Performance (2017) (7)
Surveillance for Disease Progression of Transthyretin Amyloidosis after Heart Transplantation in the Era of Novel Disease Modifying Therapies (2021) (7)
Clinical Outcomes and Quality of Life With an Ambulatory Counterpulsation Pump in Advanced Heart Failure Patients (2020) (7)
Association of preoperative infections, nasal Staphylococcus aureus colonization and gut microbiota with left ventricular assist device outcomes (2021) (7)
Adrenergic activation, fuel substrate availability, and insulin resistance in patients with congestive heart failure. (2013) (7)
Increased Bleeding Risk in LVAD Patients with Elevated Angiopoetin-2 and TNF-α: Analysis of the PREVENT Multicenter Study (2018) (7)
The future of mechanical circulatory support for advanced heart failure (2016) (7)
(1045) - The Accuracy of Physical Exam Compared to RHC in LVAD Patients (2017) (7)
Impact of worsening of aortic insufficiency during HeartMate 3 LVAD support. (2020) (7)
Impact of UNOS allocation policy changes on utilization and outcomes of patients bridged to heart transplant with intra‐aortic balloon pump (2021) (6)
108 Tricuspid Valve Repair during Left Ventricular Assist Device Insertion (2011) (6)
Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility‐Related Adverse Events in Patients With Left Ventricular Assist Devices (2020) (6)
Left Ventricular Volume Reduction and Reshaping as a Treatment Option for Heart Failure (2020) (6)
Longitudinal Trajectories of Hemodynamics Following Left Ventricular Assist Device Implantation. (2020) (6)
Center Variability in Patient Outcomes following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial. (2022) (6)
Echocardiographic Predictors of Hemodynamics in Patients Supported With Left Ventricular Assist Devices. (2018) (6)
Combined Left Ventricular Assist Device and Coronary Artery Bypass Grafting Surgery: Should We Bypass the Bypass? (2020) (6)
Normalization of Hemodynamics Following LVAD Implantation May be Related to Improved Long Term Outcome (2015) (6)
Utilization of Defibrillators and Resynchronization Therapy at the Time of Evaluation at a Heart Failure and Cardiac Transplantation Center (2010) (6)
Outcomes of heart transplantation in adult congenital heart disease with prior intracardiac repair. (2020) (6)
Laparoscopic procedures in patients with cardiac ventricular assist devices (2018) (6)
HVAD Flow Waveform Estimates Left Ventricular Filling Pressure. (2020) (6)
Fixed pulmonary hypertension and mechanical support: an unclear opportunity. (2011) (6)
Central Venous Pressure and Clinical Outcomes During Left-Sided Mechanical Support for Acute Myocardial Infarction and Cardiogenic Shock (2020) (6)
Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device. (2022) (5)
Spotlight on new therapies in heart failure. (2015) (5)
Residual native left ventricular function optimization using quantitative 3D echocardiographic assessment of rotational mechanics in patients with left ventricular assist devices (2018) (5)
Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. (2019) (5)
A Power Tracking Algorithm for Early Detection of Centrifugal Flow Pump Thrombosis (2021) (5)
Deep Y-Descent in Right Atrial Waveforms following Left Ventricular Assist Device Implantation. (2020) (5)
Reverse Ramp Testing in Left Ventricular Assist Device Support and Myocardial Recovery (2020) (5)
CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy (2020) (5)
Clinical impact, diagnosis, and management of a disconnected outflow graft bend relief in a patient supported by the HeartMate II left ventricular assist system. (2012) (5)
Effect of Concomitant Tricuspid Valve Surgery with Left Ventricular Assist Device Implantation. (2020) (5)
Exception Status Listing in the New Adult Heart Allocation System (2021) (5)
A case series analysis on the clinical experience of Impella 5.5® at a large tertiary care centre (2021) (5)
Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis (2021) (5)
Impact of Pretransplant Malignancy on Heart Transplantation Outcomes: Contemporary United Network for Organ Sharing Analysis Amidst Evolving Cancer Therapies (2022) (5)
The Prevalence of Palliative Care Consultation in Deceased COVID-19 Patients and Its Association with End-of-Life Care. (2021) (5)
Transcatheter Aortic Valve Replacement in Left Ventricular Assist Device Patients with Aortic Regurgitation (2020) (5)
Alteration in systemic vascular resistance and cardiac output during acute cellular rejection and recovery in heart transplant recipients. (2010) (5)
HVAD Waveform as a Surrogate Marker of Cardiac Index and Pulmonary Capillary Wedge Pressure (2016) (5)
Hemodynamic Effects of Concomitant Mitral Valve Surgery and Left Ventricular Assist Device Implantation (2020) (5)
Abstract 16405: Prevention of HeartMate II Pump Thrombosis - Recommendations and Preliminary Observations From the PREVENT Study (2015) (5)
First Transfemoral Implantation of a Novel Transcatheter Valve in an LVAD Patient With Aortic Insufficiency (2021) (5)
High Transpulmonary Artery Gradient Obtained at the Time of Left Ventricular Assist Device Implantation Negatively Affects Survival After Cardiac Transplantation. (2019) (5)
Hemodynamics of concomitant tricuspid valve procedures at LVAD implantation (2019) (5)
Echocardiographic evaluation of the effects of sacubitril–valsartan on vascular properties in heart failure patients (2019) (5)
Advances in mechanical circulatory support. (2016) (5)
The Prevalence of Aortic Insufficiency in Patients Maintained on Continuous Flow Left Ventricular Assist Devices (2013) (4)
Neurohormonal Blockade Reduces Adverse Events During LVAD Support (2018) (4)
Late Right Heart Failure in Destination Therapy Patients With HeartMate II Continuous Flow Device (2015) (4)
Safety of reduced anti-thrombotic strategy in patients with HeartMate 3 left ventricular assist device. (2021) (4)
Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States (2020) (4)
Obesity is not a contraindication to veno-arterial extracorporeal life support. (2021) (4)
Metabolic Dysfunction in Continuous‐Flow Left Ventricular Assist Devices Patients and Outcomes (2019) (4)
The Columbia Experience of 163 Patients with Venoarterial Extracorporeal Membranous Oxygenation for Refractory Cardiogenic Shock (2014) (4)
Partial Flow with 15F Arterial Cannula Provides Sufficient Circulatory Support in Veno-Arterial Extracorporeal Membrane Oxygenation (2014) (4)
A stepwise progression in the treatment of cardiogenic shock. (2012) (4)
Bleeding and Thrombotic Events During Extracorporeal Membrane Oxygenation for Postcardiotomy Shock. (2021) (4)
Home Inotropes in Patients Supported with Left Ventricular Assist Devices (2018) (4)
Outcomes with Implementation of Algorithmic Hemodynamic Ramps in Patients with Continuous Flow LVADs (2016) (4)
Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device (2021) (4)
Optimal Hemodynamics During LVAD Support Are Associated With Reduced Readmission Rate (2018) (4)
The Clinical Importance of Hyponatremia in Patients with Left Ventricular Assist Devices (2021) (4)
National outcomes of bridge to multiorgan cardiac transplantation using mechanical circulatory support. (2021) (4)
Chronotropic Incompetence May Impact Exercise Capacity in Patients Supported by Left Ventricular Assist Device (2013) (4)
Machine Learning-Based Prediction of Myocardial Recovery in Patients With Left Ventricular Assist Device Support (2021) (4)
A subcostal approach is favorable compared to sternotomy for left ventricular assist device exchange field of research: artificial heart (clinical) (2019) (4)
Angiotensin receptor neprilysin inhibitor use in patients with left ventricular assist devices: A single-center experience (2021) (4)
HeartWare Ventricular Assist Device Cannula Position and Hemocompatibility-Related Adverse Events (2020) (4)
Accepting Hearts From Hepatitis C-Positive Donor: Can We Expand the Donor Pool? (2017) (4)
Characteristics and Outcomes of LVAD patients with COVID-19 (2020) (4)
Impact of Venoarterial Extracorporeal Membrane Oxygenation Flow on Outcomes in Cardiogenic Shock (2021) (4)
Post-Heart Transplant Diabetes Mellitus: Incidence, Prevalence and Outcomes. (2020) (4)
Late Right Heart Failure Is Associated With Reduced Quality of Life and Functional Capacity in Continuous-Flow Left Ventricular Assist Device Recipients (2015) (4)
De-Novo Human Leukocyte Antigen Allosensitization on HeartMate 3 versus HeartMate II Left Ventricular Assist Device Recipients. (2020) (3)
Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices (2019) (3)
Predictors of Survival and Ventricular Recovery Following Acute Myocardial Infarction Requiring Extracorporeal Membrane Oxygenation Therapy (2022) (3)
Omega‐3 and hemocompatibility‐related adverse events (2019) (3)
Surgical Device Exchange Provides Improved Clinical Outcomes Compared to Medical Therapy in Treating Continuous-Flow Left Ventricular Assist Device Thrombosis. (2020) (3)
Bridge to Cancer Therapy: Can LVAD Support Allow Advanced Heart Failure Patients to Survive Cancer Treatment? (2018) (3)
Late inflow or outflow obstruction requiring surgical intervention after HeartMate 3 left ventricular assist device insertion. (2020) (3)
The Role of Aspirin in the Prevention of Coronary Allograft Vasculopathy in Cardiac Transplant Patients (2015) (3)
Long Term Outcomes for LVAD Patients Who Underwent Speed Optimization Using Pre-Discharge Ramp Test (2013) (3)
Outflow Cannula Systolic Slope in Patients With Left Ventricular Assist Devices: A Novel Marker of Myocardial Contractility (2019) (3)
Predictors of Prolonged Status 1A Wait Time Prior to Heart Transplant (2013) (3)
Neurohormonal Blockade During Left Ventricular Assist Device Support. (2020) (3)
Outcomes of Severely Obese Patients Supported by a Centrifugal-Flow Left Ventricular Assist Device. (2019) (3)
Reduction of Sympathetic Innervation Following Transition to Sacubitril/Valsartan in the Remodel (Reverse Remodeling Effects of Entresto) Study (2018) (3)
Cerebral vasoreactivity in HeartMate 3 patients. (2021) (3)
Noninvasive Physiologic Assessment of Cardiac Allograft Vasculopathy Is Prognostic for Post-Transplant Events. (2022) (3)
Oral Milrinone for the Treatment of Chronic Severe Right Ventricular Failure in Left Ventricular Assist Device Patients. (2021) (3)
Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure (2017) (3)
Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio. (2022) (3)
De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients (2021) (3)
HVAD Cannula Position and Hemocompatibility-related Adverse Events. (2020) (3)
LVAD decommissioning: A percutaneous cardiac catheterization lab approach. (2019) (3)
Increased Rate of Pump Thrombosis and Cardioembolic Events Following Ventricular Tachycardia Ablation in Patients Supported With Left Ventricular Assist Devices. (2020) (3)
Serial assessment of HeartMate 3 pump position and inflow angle and effects on adverse events. (2021) (3)
Estimation of the Severity of Aortic Insufficiency by HVAD Flow Waveform. (2019) (3)
Quantification of Aortic Insufficiency in Patients With Left Ventricular Assist Devices: A Novel Approach Combining Invasive Hemodynamics and Echocardiography (2015) (2)
(309) - Octreotide Reduces the Reoccurrence of Ventricular Assist Device Related Gastrointestinal Bleeding (2017) (2)
Changes in Left Ventricular Pacing Lead Impedance Correlate with Changes in Pulmonary Capillary Wedge Pressure during Hemodynamic Ramp Tests (2016) (2)
Optimal Hemodynamics During LVAD Support Are Associated with Reduced Hemocompatibility-related Adverse Events (2018) (2)
Cardiac transplantation in adult congenital heart disease with prior sternotomy (2021) (2)
PRESENCE OF INTRACARDIAC THROMBUS AT THE TIME OF LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION IS ASSOCIATED WITH INCREASED RISK OF STROKE AND DEATH. (2021) (2)
Cardiac transplantation in over 2000 patients: a single-institution experience from Columbia University. (2011) (2)
Incidence and Clinical Significance of Aortic Regurgitation in HeartMate 3 Continuous Flow Left Ventricular Assist Device Recipients: An Analysis from the Momentum 3 Trial Portfolio (2021) (2)
(499) – The Hemodynamic Effects of Intravascular Ventricular Assist System (iVAS) in Advanced Heart Failure Patients Awaiting Heart Transplant (2017) (2)
The role of temporary mechanical circulatory support as a bridge to advanced heart failure therapies or recovery (2022) (2)
58: Thyroid Deficiency Is Common in Advanced Heart Failure and Associated with Increased Operative Mortality after Assist Device Implantation (2010) (2)
Abstract 20395: High Incidence of Elevated Panel Reactive Antibodies in Patients Supported with HeartMate II Left Ventricular Assist Devices (2010) (2)
Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure Is the Strongest Negative Prognostic Factor Post Continuous Flow Ventricular Assist Device Implantation (2017) (2)
Fulminant Giant Cell Myocarditis Requiring Bridge With Mechanical Circulatory Support to Heart Transplantation (2022) (2)
PCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysis (2022) (2)
Estimation of Central Venous Pressure by Pacemaker Lead Impedances in Left Ventricular Assist Device Patients (2020) (2)
Extremes of Obesity and LVAD Patient Morbidity and Mortality (2015) (2)
Abstract 14812: Acute Venous Congestion Enhances Vasoconstriction, Inflammation, Oxidative stress and Endothelial Activation and in Compensated Ambulatory Patients with Systolic Heart Failure on Stable Medical Regimen (2014) (2)
Hypogammaglobulinemia following heart transplantation: Prevalence, predictors, and clinical importance (2020) (2)
The Efficacy and Safety of Belatacept in Heart Transplant Recipients (2022) (2)
Contemporary Perspectives in Durable Mechanical Circulatory Support: What Did We Learn in the Last 3 Years? (2018) (2)
Pulmonary Embolism Response Team utilization during the COVID-19 pandemic (2021) (2)
Hemodynamic Pump-Patient Interactions and Left Ventricular Assist Device Imaging. (2018) (2)
Proposal for Advanced Life Support Algorithm in Unresponsive Hospitalized LVAD Patients (2013) (2)
Improved Exercise Performance and Quality of Life with Right Ventricular Pacing Over Biventricular Pacing in LVAD Patients (2018) (2)
Incidence and clinical correlates of de‐novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis (2022) (2)
Management of a Counterpulsation Device Outside of the Intensive Care Unit (2017) (2)
Development of De Novo Aortic Insufficiency in Patients with HeartMate 3. (2021) (2)
Twenty-four-hour blood pressure and heart rate variability are reduced in patients on left ventricular assist device support. (2022) (2)
Adjunctive pharmacotherapy for coronary interventions—time to read the writing on the wall (2006) (2)
The difference between cystatin C‐ and creatinine‐based assessment of kidney function in acute heart failure (2022) (2)
Upfront RVAD Strategy and Early Clinical Outcomes in LVAD Patients. (2020) (2)
269 Aortic Valve Repair at the Time of Continuous-Flow Left Ventricular Assist Device Implantation (2011) (2)
Highly Accurate Continuous Blood Pressure Measurement in LVAD Patients with a Non-Invasive, Non-Oscillometric Wearable Device: A Pilot Study (2018) (2)
Acute Myocarditis Secondary to Reactivated Chromosomally-Integrated Human Herpesvirus 6. (2017) (2)
The use of telemedicine in cardiogenetics clinical practice during the COVID‐19 pandemic (2022) (2)
State of the Art Review: Evolution and Ongoing Challenges of Left Ventricular Assist Device Therapy (2018) (2)
A passionate endurance cyclist ultimately survives sudden death in right ventricular giant cell myocarditis. (2014) (2)
Aortic Pulsatility Index: A Novel Hemodynamic Variable for Evaluation of Decompensated Heart Failure. (2021) (2)
The benefits and safety of external counterpulsation in symptomatic heart failure. (2006) (2)
Advanced Heart Failure Therapy in HIV Positive Patients: Do These Patients Get Equal Treatment? (2013) (2)
Right Ventricular Pressure-Volume Analysis during LVAD Speed Optimization Studies: Insights into Interventricular Interactions and Right Ventricular Failure. (2021) (2)
A Rare Case of Disseminated Tuberculosis and Hematological Malignancy in a Heart Transplant Recipient. (2021) (2)
Role of left atrial appendage occlusion in patients with HeartMate 3 (2021) (2)
Surveillance for Transthyretin Amyloidosis Progression after Heart Transplantation in the Era of Novel Disease Modifying Therapies (2021) (2)
Outcomes following left ventricular assist device exchange (2020) (2)
Changes in waitlist and posttransplant outcomes in patients with adult congenital heart disease after the new heart transplant allocation system (2021) (2)
The Use of Cardiac Resynchronization Therapy in Patients Supported By Continuous-Flow Left Ventricular Assist Device (2015) (1)
The Impact of Age, Sex, Therapeutic Intent and Severity of Advanced Heart Failure on Outcomes in the Multicenter Study of Maglev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with Heartmate 3 (Momentum 3) Pivotal Trial (2017) (1)
Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure (2021) (1)
419: Heart Transplantation in HIV Positive Patients (2009) (1)
LVAD Outflow Cannula Systolic Slope in Patients with Left Ventricular Assist Devices: A Marker of Myocardial Contractility (2016) (1)
Impact of Heart Failure Drug Therapy on GI Bleeding Rates in LVAD Recipients: An INTERMACS Analysis. (2020) (1)
Spotlight on cardiogenic shock therapies in the era of mechanical circulatory support. (2014) (1)
Use of Impella 5.0 Ventricular Assist Device as a Bridge to Decision during Acute Decompensation of End-Stage Chronic Heart Failure (2016) (1)
Abstract 19448: Ventricular Arrhythmias in Patients Following Continuous Flow Left Ventricular Assist Device Implantation (2012) (1)
363 Continuous-Flow LVAD Destination Therapy Versus Orthotopic Heart Transplantation in Patients above 65 Years of Age (2011) (1)
Early Clinical Experience with Impella 5.5 at a Large Tertiary Care Center (2021) (1)
Detailed Endocardial Mapping Around the Left Ventricular Assist Device Inflow Cannula Facilitates Successful Ablation of Ventricular Tachycardia (2015) (1)
Enhanced Thrombin Formation in Patients With Ventricular Assist Devices Experiencing Bleeding: Insights From the Multicenter PREVENT Study (2022) (1)
192 Psychosocial Evaluation before Left Ventricular Assist Device Implantation Can Predict Device Complication during Support (2011) (1)
Remote Monitoring of Heart Transplant Recipients during the COVID-19 Pandemic (2021) (1)
Post-Transplant Outcomes of Pediatric Patients Bridged with Continuous Flow Left Ventricular Assist Devices (2014) (1)
Refusal of Blood Products Should Not be a Contraindication to LVAD Therapy (2018) (1)
Novel Formula to calculate 3-D Angle between Inflow Cannula and Device Body of HeartMate II LVAD. (2019) (1)
Is it Possible to Implant and Manage Patients with Durable LVADs Who Refuse Blood Products? (2019) (1)
Use of Letermovir for Cytomegalovirus (CMV) Prophylaxis in Orthotopic Heart Transplant Recipients (2022) (1)
Interventional cardiology in Israel at 2005—state of practice (2007) (1)
Continuous Intermittent Intravenous Immunoglobulin in Heart Transplant Recipients with Elevated Donor-Specific Antibody Levels (2021) (1)
OUTCOMES OF MECHANICAL CIRCULATORY SUPPORT FOR REFRACTORY CARDIOGENIC SHOCK IN THE ERA OF MORE ADVANCED VENTRICULAR ASSIST DEVICES (2012) (1)
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Crisis Standards of Care. (2021) (1)
Incidence and Clinical Significance of Hyperkalemia Following Heart Transplantation (2019) (1)
The Clinical Importance of Functional Mitral Regurgitation and Atrial Fibrillation in Patients with Left Ventricular Assist Device. (2020) (1)
Combined Heart Kidney Transplantation in a Previous Heart Transplant Recipient with Pheochromocytoma and Monoclonal Gammopathy of Uncertain Significance (2022) (1)
The Weight is Over...Obesity Does Not Adversely Affect Venoarterial Extracorporeal Membrane Oxygenation Outcomes (2021) (1)
Aortic Insufficiency and Clinical Outcomes in Patients Undergoing Aortic Valve Procedures at the Time of Continuous Flow Left Ventricular Assist Device Implantation (2013) (1)
Association Between Oral Microbiome, Inflammation, Endotoxemia, and Heart Failure Severity (2022) (1)
Nitric oxide synthase inhibitors in cardiogenic shock: present and future. (2008) (1)
The Role of Serial Right Heart Catheterization Survey in Patients Awaiting Heart Transplant on Ventricular Assist Device (2021) (1)
Outcomes Following Mitraclip in Advanced Heart Failure Patients: A Meta-Analysis (2018) (1)
Increased Angiogenesis and Non-Surgical Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices Are Mediated by Thrombin-Induced Angiopoietin-2 (2016) (1)
The Novel Hemodynamic Variable Aortic Pulsatility Index Predicts Freedom from Advanced Heart Failure Therapies and Death. (2020) (1)
Subcostal vs. Sternotomy Device Exchanges: Comparison of Long-Term Mortality and Re-Exchange (2014) (1)
INCIDENCE, PREDICTORS, AND OUTCOME OF POSTOPERATIVE ATRIAL FIBRILLATION IN PATIENTS RECEIVING CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICES (2017) (1)
(82) - Increased Rate of Pump Thrombosis and Cardioembolic Events Following Ventricular Tachycardia Ablation in Patients Supported with Left Ventricular Assist Devices (2017) (1)
Nitric Oxide Synthase Inhibitors in Refractory Cardiogenic Shock due to Myocardial Infarction after Percutaneous Coronary Intervention (2005) (1)
Sex Differences in Characteristics and Outcomes Following HeartMate 3 Left Ventricular Assist Device Implantation. (2020) (1)
Cardiac Allograft Vasculopathy in HIV-Infected Patients (2013) (1)
Rapid (2 Minutes) Clinical Assessment of Respiratory Failure (Oxygen Saturation) and Circulatory Failure (Systolic Blood Pressure) – An Easy and Acurate Way To Risk Stratify Patients with Acute Heart Failure at Admission? (2006) (1)
Wait List Outcomes of Pediatric Patients Bridged to Heart Transplantation on the CF-LVADs Left Ventricular Assist Device (2014) (1)
Normal Serum Lactic Acid is Discordant with Shock in Advanced Heart Failure Patients (2018) (1)
Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach. (2022) (1)
Infections and Subsequent Events in the ENDURANCE and ENDURANCE Supplemental Trials (2018) (1)
Impact of Residual Secondary Mitral Regurgitation on Clinical Outcomes after LVAD Implantation: An Analysis from the MOMENTUM 3 Pivotal Trial and Continuous Access Protocol Study. (2020) (1)
HeartMate II Device Exchange: Single Center Experience (2013) (1)
Abstract 18677: A Quantitative Analysis of Pump Parameters in the HeartWare Left Ventricular Assist Device System for the Identification and Management of Pump Thrombus (2014) (1)
Acute Myocardial Failure After Liver Transplantation: Tako-Tsubo or Undiagnosed Cirrhotic Cardiomyopathy?: Abstract# D2626 (2014) (1)
Discordance between immunofluorescence and immunohistochemistry C4d staining and outcomes following heart transplantation (2021) (1)
Genome-Wide DNA Methylation Profiling of the Failing Human Heart with Mechanical Unloading Identifies LINC00881 as an Essential Regulator of Calcium Handling in the Cardiomyocyte (2022) (1)
Reduction of Drive Line Infection in Continuous Flow Assist Devices: Use of Standard Kit Including Silver Dressing and Anchoring Device (2014) (1)
Pulmonary Artery Pulsatility Index (PAPi) is a Predictor of Right Ventricular Assist Device (RVAD) Use Following HeartMate 3 LVAD Implantation. (2020) (1)
The Location of Intractable Ventricular Arrhythmias Following Left Ventricular Assist Device Implantation (2015) (1)
Pre-transplant Anti-nuclear Antibodies Correlate With Post-transplant Donor-specific Antibodies: A Link between Autoimmunity and Graft Failure? (2018) (1)
TAVI in LVAD Patients with Aortic Insufficiency (2019) (1)
Predictors of 1‐year outcome after cardiac re‐transplantation: Machine learning analysis (2022) (1)
USE OF EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION IN A CASE OF CARDIAC ARREST DUE TO ETHYLENE GLYCOL POISONING (2021) (1)
Influence of Atrial Fibrillation on Functional Tricuspid Regurgitation in Patients With HeartMate 3 (2021) (1)
(888) - Destination to Nowhere: The Ethics of Acute Mechanical Circulatory Support (2017) (1)
Shared Care Program for Left Ventricular Assist Device (LVAD) Patients: Clinical Experience and Interim Report (2022) (1)
Increased Right Ventricular Assist Device (RVAD) Utilization in Patients with HeartMate 3 Left Ventricular Assist Device (LVAD) in the Post-Approval Era. (2020) (1)
Surgical Management of Chemotherapy-Induced End-Stage Heart Failure (2010) (1)
Clopidogrel Does Not Increase Incidence of Bleeding in LVAD Patients (2016) (1)
Outflow Cannula Systolic Slope as a Predictor of Myocardial Recovery Leading to Successful LVAD Decommission: A Case Series. (2020) (1)
Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy (2022) (1)
Heart transplantation in patients with localized prostate cancer—Are we denying a life‐saving therapy due to an indolent tumor? (2020) (1)
Utility of Gene Expression (Allomap Score) in Antibody Mediated Rejection Detection (2016) (1)
Results of Jehovah’s Witnesses Undergoing Surgical Treatment of Advanced CHF (2015) (1)
Outcomes of mechanical support for cardiogenic shock associated with late cardiac allograft failure (2020) (1)
(301) - Increased Tumor Necrosis Factor-α Levels in Patients with Continuous-Flow Left Ventricular Assist Devices Mediate Vascular Instability and Are Associated with Higher Non-Surgical Bleeding (2017) (1)
Noninvasive Assessment of Lung Fluid Percentage in Heart Transplant Recipients Using Remote Dielectric Sensing (2017) (1)
Temporary surgical ventricular assist device for treatment of acute myocardial infarction and refractory cardiogenic shock in the percutaneous device era (2021) (1)
Open Chest Epicardial Voltage Mapping during Left Ventricular Assist Device Implant in Patients with End-Stage Heart Failure (2016) (1)
Development of De Novo Aortic Insufficiency in Patients with HeartMate 3. (2020) (1)
Use of Extracorporeal Membrane Oxygenation in Ranolazine Overdose (2023) (1)
Impact of Aortic Insufficiency on Unloading Properties of Continuous-Flow Left Ventricular Assist Devices (2016) (1)
ASSESSMENT OF LEFT VENTRICULAR ROTATIONAL MECHANICS POST-LVAD IMPLANTATION USING 3D ECHOCARDIOGRAPHY (2017) (1)
216 Effect of LVAD on the Prognostic Value of Baseline GFR for Long Term Renal Function in Patients Undergoing Heart Transplant (HTX) (2011) (1)
Discordance between Thermodilution and Indirect Fick Cardiac Output Measurements in LVAD Patients (2016) (1)
C-Reactive Protein Levels Predict Outcomes in Continuous-Flow Left Ventricular Assist Device Patients: An INTERMACS Analysis (2021) (1)
Cardiac Arrest in the Era of Mechanical Circulatory Support: A Single Center Experience with Extracorporeal Cardiopulmonary Resuscitation (2014) (1)
Incidence and Cause of Persistent Low Flow Alarm after HeartMate 3 Left Ventricular Assist Device Insertion. (2020) (1)
Outcomes of Patients Bridged with Acute Mechanical Circulatory Support Devices to HeartMate 3. (2020) (1)
Molecular Pathophysiology of Cardiac Injury and Cardiac Microthrombi in Fatal COVID-19: Insights from Clinico-histopathologic and Single Nuclei RNA Sequencing Analyses (2021) (1)
Omega-3 Reduces Gastrointestinal Bleeding in Patients With Continuous-flow Left Ventricular Assist Device (2018) (1)
Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life: The RAMP-IT-UP Multicenter Study (2019) (1)
Unclear Benefit of Cardiac Resynchronization Therapy in Patients with Implanted Left Ventricular Assist Devices. (2018) (1)
(460) - Cardiac Resynchronization Therapy Reduces Mortality and Cardiovascular Readmissions in Left Ventricular Assist Device Recipients (2017) (1)
It's All in the Tissue: A Rare Case of Acute Cardiogenic Shock. (2019) (1)
Forward "MOMENTUM" in left ventricular assist systems: advanced engineering meets biology. (2017) (1)
The Impact of Socioeconomic Status on Outcomes Following Left Ventricular Assist Device Implantation at a Single Center. (2020) (1)
Correlation of ImmuKnow Assay Levels with Rejection and Infection after Heart Transplantation (2019) (1)
CORRELATION OF NONINVASIVE ASSESSMENT OF LUNG FLUID PERCENTAGE WITH INVASIVELY MEASURED HEMODYNAMICS (2017) (1)
(525) - Consequence of Retained Defibrillator and Pacemaker Leads Following Heart Transplantation - An Under-Sensed Problem? (2017) (1)
Circulating Monocyte Subtypes Correlate with Cardiac Allograft Vasculopathy and Differ from Atherosclerotic Disease: A Tool for Monitoring? (2018) (1)
Heart Failure Clinicians Want to Revive the REVIVE-IT Study Following the Results of the MOMENTUM 3 and ENDURANCE Supplement Trials (2018) (1)
Estimation of Total Cardiac Output Using Non-Invasive Parameters in HeartMate 3 Patients (2021) (1)
A principal components analysis of factors associated with successful implementation of an LVAD decision support tool (2020) (1)
PCI in Patients Supported With CF-LVADs: Indications, Safety, and Outcomes. (2016) (1)
Pneumonia in the First Year after Heart Transplant: Epidemiology, Risk Factors, and Effect on Survival (2010) (1)
Special Considerations for Durable Left Ventricular Assist Device Use in Small Patients. (2022) (1)
Clinical and Hemodynamic Efficacy of Left Ventricular Unloading during Venoarterial Extracorporeal Membrane Oxygenation (2021) (1)
Should it be called "Suicide" or "Withdrawal of LVAD support"? (2020) (1)
Relationship Between Speed and Left Ventricular Size in HVAD Patients: Lessons from the HVAD Ramp Test Study (2014) (1)
Angiotensin Receptor Neprilysin Inhibition in Patients with Left Ventricular Assist Devices. (2020) (1)
Myocardial Microvascular Density Increases After Chronic Continuous Flow Left Ventricular Assist Device (CF-LVAD) Support (2014) (1)
Impact of socioeconomic deprivation on evaluation for heart transplantation at an urban academic medical center (2022) (1)
581 Physical Therapy for Patients with External Ventricular Assist Device (2012) (1)
The Safety of Right Heart Catheterization in Patients with Continuous-Flow Left Ventricular Assist Devices (2015) (1)
Outcomes in Smaller Body Size Adults after HeartMate 3 Left Ventricular Assist Device Implantation. (2022) (0)
Residual Lung Injury Following HeartMate 3 Explantation for Heart Transplant. (2020) (0)
Driveline Infection in LVAD Patients: Effect of Era, Pump Type and Treatment Strategy. (2020) (0)
Abstract 11799: Omega-3 Therapy is Associated With Reduced Hemocompatibility-Related Adverse Events Following Left Ventricular Assist Device Implantation (2018) (0)
HVAD Cannula Positioning is Associated with Higher GI Bleed Rates (2019) (0)
Safety of Mechanical Circulatory Support as a Bridge to Cardiac Retransplantation (2014) (0)
Impact of Pre-Heart Transplant Pulmonary Function Tests on Post-Transplant Pulmonary Outcomes (2022) (0)
Psychosocial Contraindications to Heart Transplant Listing in an Urban Academic Medical Center (2019) (0)
SUCCESSFUL RESTORATION OF HEART RATE RESPONSIVENESS TO EXERCISE USING CARDIAC RESYNCHRONIZATION THERAPY DELAYS ANAEROBIC THRESHOLD IN PATIENTS WITH ADVANCED HEART FAILURE (2010) (0)
Device Exchange Is Superior to Medical Therapy for Treating Continuous-Flow Left Ventricular Assist Device Thrombosis (2017) (0)
Editorial introductions. (2018) (0)
(440) – Echocardiographic Predictors of Hemodynamics in Patients Supported with Left Ventricular Assist Devices (2017) (0)
(314) - 3D Echocardiography and Shape Analysis Changes Following Left Ventricular Assist Device Implantation: The Effect of Unloading on Reverse Remodeling (2017) (0)
Partial Flow Extracorporeal Life Support Strategy for Refractory Cardiogenic Shock (2022) (0)
Hemocompatibility of an Ambulatory Counterpulsation Circulatory Assist System (2018) (0)
Impact of Perioperative Dysphagia and Oral Microbiome on Postoperative Pneumonia after LVAD (2023) (0)
Characteristics and Outcomes of Recipients of Heart Transplant with Coronarvirus Disease 2019 Who Received Casirivimab Plus Imdevimab Infusion (2022) (0)
099 - Gender's Effect on Hemodynamic Unloading and Readmissions in Patients Supported with Left Ventricular Assist Devices (LVADs) (2017) (0)
471: Combined Heart Kidney Retransplant Has Lower Survival than De Novo Transplant (2010) (0)
LVHNet: Detecting Cardiac Structural Abnormalities with Chest X-Rays (2021) (0)
Impact of Pulse Pressure on Hemocompatibility Related Adverse Events during Support with Continuous Flow Left Ventricular Assist Devices: An Analysis of the INTERMACS Registry. (2020) (0)
Acute Kidney Injury During Extracorporeal Life Support in Cardiogenic Shock: Does Flow Matter? (2022) (0)
3D Surface Analysis of RV and LV Shapes as Predictors of Post-LVAD RV Failure (2016) (0)
Pseudomonas aeruginosa Infection Predicts Need for Surgical Incision and Drainage in LVAD Patients with Driveline Infection (2021) (0)
Long-Term Outcome of Cardiac Transplant After Continuous-Flow Left Ventricular Assist Device Support (2014) (0)
Cardiovascular Case Series 1703 Foreword (0)
Acute Heart Failure Associated with High Admission Blood Pressure – A Very Common, yet Distinct Vascular Disorder? (2006) (0)
463: RVSWI Is an Independent Predictor of Need for MCS and/or HT in Stable Outpatients with NYHA Class III HF (2010) (0)
36 Right-to-Left Hemispheric Predominance of Cerebrovascular Lesions and Its Association with Systemic Infection in Patients Undergoing Left Ventricular Assist Device Implantation (2012) (0)
The Association of Sarcopenia with Gut Dysbiosis and Inflammation in Heart Failure, LVAD and Heart Transplant Patients (2021) (0)
Does Mechanical Circulatory Support Prior to Heart Transplantation Influence Early Onset of Coronary Allograft Vasculopathy (2013) (0)
Serial Assessment of Magnetically Levitated Centrifugal-Flow LVAD Pump Position and Inflow Angle on Chest Radiograph and Effects on Adverse Events. (2020) (0)
Association of Plasma Trimethylamine-N-oxide and Serum Endothelin-1 with Cardiac Allograft Vasculopathy in Heart Transplant Recipients. (2020) (0)
Advanced Heart Failure Patients Supported with Ambulatory Inotropic Therapy: What Defines Success of Therapy? (2021) (0)
Placement of a Fully Magnetically Levitated Left Ventricular Assist Device: Intrathoracic versus Intrapericardial. (2020) (0)
Myocardial Flow Reserve by N13 Ammonia Positron Emission Tomography Predicts Post-Heart Transplant Outcomes. (2020) (0)
Impact of Perioperative Sarcopenia and Dysphagia on LVAD Related Complications (2023) (0)
(272) - Left Atrial Appendage Occlusion Is Associated with Decreased Thromboembolic Events in LVAD Patients (2017) (0)
Abstract 19296: Clinical Accuracy of Physical Exam in Decompensated Heart Failure Patients Admitted to the Cardiac Care Unit (2017) (0)
Biomarkers of Inflammation and Oxidative Stress in HeartMate II vs HeartMate 3 Patients. (2020) (0)
Persistently Elevated Donor-Derived Cell-Free DNA in Heart Transplant Recipients (2023) (0)
AORTIC ROOT THROMBOSIS IS ASSOCIATED WITH INCREASED INCIDENCE OF AORTIC INSUFFICIENCY IN PATIENTS SUPPORTED WITH HEARTMATE 3 LEFT VENTRICULAR ASSIST DEVICE (2021) (0)
The Role of Palliative Care Consultation in Withdrawal of Veno-Arterial Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock. (2020) (0)
(1340) - A Subcostal Approach Is Favorable Compared to Full Sternotomy for Continuous-Flow Left Ventricular Assist Device Exchange (2017) (0)
Low Left Ventricular Stroke Work Index is Associated with a Poor Prognosis in LVAD Patients (2021) (0)
INCREASED INCIDENCE OF AORTIC INSUFFICIENCY IN HEARTMATE II COMPARED TO HEARTMATE I LEFT VENTRICULAR ASSIST DEVICE RECIPIENTS (2010) (0)
754 Benefits of ECPT in heart failure patients: mystery behind the curtain (2005) (0)
Functional Assessment of Decellularized Extracellular Matrix in Patients Undergoing LVAD Implantation (2019) (0)
Clinical Outcome and Quality of Life with an Ambulatory Counterpulsation Pump (iVAS) in Advanced Heart Failure Patients (2018) (0)
A Long-Term Counterpulsation Heart Assist System Used as a Bridge to Decision in Advanced Congestive Heart Failure (2019) (0)
On the Right Path: Predicting Right Ventricular Failure After Left Ventricular Assist Device. (2022) (0)
Cardiovascular and Heart Failure Management of COVID-19: The New York Experience (2022) (0)
(357) - Normalization of Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure in Response to Speed Change Predicts Better Outcome in Patients with Left Ventricular Assist Devices (2017) (0)
247 Peak Exercise Capacity in Continuous-Flow Left Ventricular Assist Device Recipients May Be Determined by Right Ventricular Performance (2012) (0)
Abstract 17258: The Relationship Between D-Dimer Levels and Deep Venous Thrombosis in COVID-19: An Analysis From a Quaternary Academic Medical Center in New York City (2020) (0)
526 The daily incidence of acute heart failure is strongly correlated with same and previous day cold weather conditions. Cold immersion pulmonary edema revisited (2004) (0)
Low Levels of Inflammation and Congestion at the First Outpatient Visit after LVAD Implant Predict Lower Risk for Readmission and More Days-Alive-out-of-Hospital (2021) (0)
792 Feasibility and Flexibility of Magnetically Levitated Centrifugal-Flow Pump for Patients with Cardiogenic Shock (2012) (0)
746 Speed Adjustment and Thrombosis Detection in Continuous Flow Pumps: Utility of Ramp Studies (2012) (0)
BODY MASS INDEX AND OUTCOMES OF PATIENTS SUPPORTED BY THE HEARTWARE VENTRICULAR ASSIST SYSTEM (2016) (0)
(885) - Subclavian Artery Access Intra-Aortic Balloon Pump (sIABP): An Excellent Value-Based Bridge to Transplant Therapy (2017) (0)
Tacrolimus Time in Therapeutic Range is Associated with Cellular Rejection and Gut Dysbiosis Early after Heart Transplant (2021) (0)
New System, Familiar Problem: Increased Wait Time for High Priority Heart Transplant Candidates (2023) (0)
AORTIC ROOT THROMBOSIS IN PATIENTS WITH HEARTMATE 3 LEFT VENTRICULAR ASSIST DEVICES (2021) (0)
Omega-3 Suppresses Gastrointestinal Bleeding by Reducing Angiopoietin-2 Expression in LVAD Patients (2019) (0)
Advances in cardiac transplantation. (2017) (0)
GI Bleeding in LVAD Patients Management and Prevention of GIB Diagnosis of GIB Diagnosing (2018) (0)
Deep Y-Descent in Right Atrial Waveforms is Associated with RV Dysfunction and Worse Outcome in LVAD Patients (2019) (0)
Preoperative Left Ventricular Diastolic Dimension Index Predicts Outcomes after Heartmate 3 Implantation (2023) (0)
Absence of Aortic Valve Opening after Hemodynamic Ramp Optimization Study Does Not Impact LVAD Morbidity of Mortality. (2020) (0)
The Impact of Small Left Ventricular Dimension on Outcomes after HeartMate 3 LVAD Implantation (2023) (0)
Comparison of Survival and Readmission Rates in Patients 65 and Older Undergoing Heart Transplantation or LVAD Implantation (2018) (0)
Survival and Readmission Rates Following LVAD Exchange (2018) (0)
Impact of preheart transplant spirometry and DCLO measurement on post-transplant pulmonary outcomes. (2023) (0)
HM3 Patients Do Not Have an Increased Pulsatility in Large, Muscular or Microcirculatory Arteries. (2020) (0)
068 - Changes in Pulmonary Artery Pressure Utilizing Remote Monitoring Data after Left Ventricular Assist Device Implantation (2017) (0)
786 Isolated Right Ventricular Assist Device Support Does Not Predict Better Survival over Biventricular Support for Primary Graft Failure after Orthotopic Heart Transplant (2012) (0)
Changes in Metabolic Profiles Following Left Ventricular Assist Device Implantation (2018) (0)
Progression of Tricuspid Regurgitation after Heart Transplantation with Concomitant Tricuspid Valve Annuloplasty (2019) (0)
The Utility of Televisits in Heart Transplant Recipients (2021) (0)
Cardiac Allograft Vasculopathy is Linked to Impaired Generation of Regulatory M2 Macrophages (2019) (0)
Implantable Ventricular Assist Device Use in the Immunosuppressed Patient (2013) (0)
(56) - First-in-Human (FIH) Experience with the Intravascular Ventricular Assist System iVAS a Novel Approach to Mechanical Circulatory Support (2017) (0)
Assessment of Cerebrovascular Reserve in the Heart Failure Patients Supported with the HeartMate3. (2020) (0)
Contemporary Outcomes of Heart Transplantation in Adult Patients with Congenital Heart Disease and Prior Intracardiac Repair: Analysis from UNOS Database. (2020) (0)
Straining with the ventricular assist device and right ventricular function. (2013) (0)
Discordance Between Clinical and Invasive Assessment of Hemodynamics in Patients with Decompensated Heart Failure (2018) (0)
Estimation of Mean Arterial Pressure Using Doppler and Pump Parameters in HeartMate 3 Patients. (2020) (0)
Clinical Predictors of 5-year Outcomes Following Heartmate 3 Left Ventricular Assist Device Implant: The Momentum 3 Trial (2023) (0)
The Use of Contractile Reserve Dobutamine Echocardiography for Recovery Prediction in Chemotherapy Associated Cardiomyopathy (2018) (0)
Pre-Operative Intracardiac Thrombus is Associated with Increased Risk of Stroke and Death in CF-LVAD Patients. (2020) (0)
New-Onset Diabetes in Patients Post-Heart Transplantation; the Role of Hypertension and Novel Diabetic Medications (2022) (0)
A root cause analysis of ‘falsely elevated’ oxygen saturation: investigation of pneumatic tube transport and differences between estimated and measured saturation in a critical patient population (2019) (0)
Aortic Insufficiency is Associated with Hemocompatibility-Related Adverse Events in LVAD Patients (2019) (0)
Sex-Based Differences in Survival and Readmissions After Insertion of HeartMate3 (HM3) Left Ventricular Assist Device (2022) (0)
Mean Arterial Pressure is Not Associated with Hemocompatibility-Related Outcomes in LVAD Patients (2021) (0)
357: Acquired Von Willebrand Disease Frequently Occurs in Continuous Flow Left Ventricular Assist Devices (2010) (0)
(1061) - Configuration of Extracorporeal Circulation and Association with Outcomes (2017) (0)
552 Recurrent worsening heart failure is the most common morbidity in patients admitted with acute heart failure: time course and outcome (2004) (0)
Discordance between C4d Staining by Immunohistochemistry and Immunofluorescence and Clinical Outcomes (2016) (0)
Opioid Use in LVAD Patients is Associated with Increased GI Bleed and Sepsis (2019) (0)
Physiology of Blood Pump Circulation in Heart Failure (2020) (0)
Postoperative tolvaptan use in left ventricular assist device patients: The TOLVAD randomized pilot study. (2022) (0)
Society for Cardiovascular Angiography and Interventions Shock Classification to Stratify Outcomes of Extracorporeal Membrane Oxygenation (2022) (0)
Pulmonary Artery Decoupling Further Enhances Discriminatory Power of Pulmonary Vascular Resistance in Patients Bridged to Transplant with Left Ventricular Assist Devices (2018) (0)
Less is better? Comparing effects of median sternotomy and thoracotomy surgical approaches for left ventricular assist device implantation on postoperative outcomes and valvulopathy. (2022) (0)
Providers and Patients Differ in Their Opinions on Travel for Organ Transplantation (2021) (0)
Home INR Monitoring: Does It Help Reduce the Chance of Re-Admission for LVAD Patients? (2013) (0)
Impact of Rejection Surveillance Practices on Outcomes after Heart Transplantation (2023) (0)
Bridging to Transplant with HeartMate 3 Left Ventricular Assist Device in the 2018 Heart Allocation System (2022) (0)
(549) - Noninvasive Assessment of Lung Fluid Percentage in Advanced Heart Failure Patients (2017) (0)
Abstract 19080: Peak Exercise Capacity is a Poor Indicator of Functional Capacity for Patients Supported by a Continuous Flow Left Ventricular Assist Device (2013) (0)
Concomitant Valvular Procedures During LVAD Implantation and Outcomes: An Analysis of the MOMENTUM 3 Trial Portfolio (2022) (0)
330: Blood Product Requirements during Heart Transplantation Are Significantly Higher in Patients Bridged with Continuous Flow Devices Compared to Pulsatile Flow Devices (2010) (0)
422: Clinical Outcome of Orthotopic Heart Transplantation for End-Stage Heart Disease Due to Mediastinal Radiation Therapy (2009) (0)
Elevated Central Venous Pressure As A Trigger For Right Heart Failure Evaluation In Patients Receiving Left-sided Mechanical Support For Cardiogenic Shock (2020) (0)
090 - The Effect of Neurohormonal Blockade in Patients Supported with LVAD (2017) (0)
Hypogammaglobulinemia Following Heart Transplantation - Prevalence and Clinical Importance. (2020) (0)
MULTIMODALITY ANALYSIS OF ABNORMAL MYOCARDIAL PERFUSION IN POST-HEART TRANSPLANT RECIPIENTS (2017) (0)
Normalization of Metabolic Status after LVAD Implantation is Associated with Heart Failure Free Survival (2019) (0)
Validation of the Heartmate 3 Survival Risk Score in a Large Left Ventricular Assist Device Center (2023) (0)
Low Serum TNF-α in a European Cohort Implanted with the HeartMate3 Left Ventricular Assist Device (2018) (0)
Abstract 18842: Point of Care Testing Overestimates INR in CF-LVAD Patients (2014) (0)
Correlation Between Anti-Factor Xa, Activated Partial Thromboplastin Time, Activated Clotting Time, and R Time in Patients Supported With Continuous-Flow Left Ventricular Assist Devices (2016) (0)
Outcomes of Mechanical Circulatory Support Therapy for Cardiogenic Shock Associated with Late Allograft Failure after Heart Transplantation. (2020) (0)
Cardiac Power Output and Cardiac Power Efficiency Show Prognostic Value in LVAD Patients (2021) (0)
Preclose Cinching “C-Stitch” to Aid Hemostasis After Impella Insertion (2022) (0)
Reliability of a Novel Slow Cuff-Deflation System for Non-Invasive Blood Pressure Monitor in Out-Patients with Continuous-Flow Left Ventricular Assist Devices (2011) (0)
Accurate Quanti ﬁ cation Methods for Aortic Insuf ﬁ ciency Severity in Patients With LVAD of Systolic-to-Diastolic (0)
(647) - The Effect of HeartMate2 and HeartMate3 Implantation on Plasma Markers of Angiogenesis and Inflammation (2017) (0)
381 Whoa Baby! Successful Vaginal Delivery in a Woman with a Dilated Cardiomyopathy Supported with a Left Ventricular Assist Device (2011) (0)
Detecting early physiologic changes through cardiac implantable electronic device data among patients with COVID-19 (2022) (0)
THE HEMODYNAMIC EFFECTS OF INTRAVENOUS INOTROPE/VASODILATOR THERAPY IN THE BETA-BLOCKER ERA (2016) (0)
Increased Nocturnal Arterial Stiffness is Associated with a Higher Risk of Stroke in LVAD Patients (2022) (0)
The Utility of Televisits in Patients with Cardiac Amyloidosis during the COVID-19 Pandemic (2021) (0)
Abstract 17790: Can 3D Echocardiography Play a Role in Left Ventricular Assist Device Optimization? (2014) (0)
Multi-Organ Transplantation in Hiv-Positive Recipients - Patient Characteristics and Outcomes (2023) (0)
Worsening of Right Heart Function Following Left Ventricular Assist Device Implantation - Right Heart Catheter Waveform Analyses (2019) (0)
Six-Month Outcomes of Heart Transplant Recipients Infected by COVID-19 (2021) (0)
342 - Predictors and Characteristics of Pericardial Effusions Post OHT (2017) (0)
Monocyte Gene Expression before and after LVAD Implantation (2016) (0)
Evaluation of Donor Derived Cell-Free DNA in ABO Mismatched Heart Transplant Patients (2023) (0)
The daily incidence of acute heart failure is strongly correlated with cold weather conditions and air pollution. cold immersion pulmonary oedema revisited (2004) (0)
Short-Term Ventricular Structural Changes Following Left Ventricular Assist Device Implantation. (2020) (0)
Outcomes of Patients Supported with Heartmate Three Left Ventricular Assist Device for More Than Two Years (2022) (0)
Left Ventricular Unloading in Relation to Cannula Position during Invasive Hemodynamic Ramp Test in Axial Flow Pumps (2016) (0)
Abstract 15597: Acute Venous Congestion Causes Angiotensin II formation via Angiotensin-Converting Enzyme Activation in Compensated Ambulatory Patients with Systolic Heart Failure (2014) (0)
Letter by Rosner et al regarding article, "When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure". (2013) (0)
Shared Decision Making In Cardiology Practice: 15 Month Results of A Multi-Site Study of Decision Aid Implementation (2020) (0)
Multislice cardiac tomography in a patient with absolute contraindication for cardiac catheterization. (2008) (0)
(901) - Utility of Cardiac Magnetic Resonance Imaging (CMR) in the Evaluation of Heart Transplant (HT) Patients with Suspected Rejection (2017) (0)
PULMONARY ARTERIAL HYPERTENSION WITH CONCOMITANT LEFT VENTRICULAR DYSFUNCTION: A CHALLENGING CLINICAL SCENARIO (2019) (0)
The Difference Between Cystatin C- and Creatinine-Based eGFR in Heart Failure With Reduced Ejection Fraction: Insights From PARADIGM-HF. (2023) (0)
Ambulatory Counter Pulsation at Home- A Dream that Became a Reality (2018) (0)
HIGH PREVALENCE OF BLEEDING WITH CONTINUOUS FLOW DEVICES (2010) (0)
Pulmonary Artery Pressures During Cardiopulmonary Exercise Testing Using Cardiomems (2022) (0)
536 Reduced Antithrombotic Therapy as an A Priori Strategy in HM II Recipients: A Word of Caution (2012) (0)
The Effect of Persistently Elevated Dd-Cfdna with De-Novo Donor Specific Antibody on Heart Transplant Recipients Outcomes (2023) (0)
Elevated Outpatient C-Reactive Protein Independently Predicts Stroke and Gastrointestinal Bleeding in LVAD Patients. (2020) (0)
Five -Fold Increase in Antibody-Mediated Rejection (AMR) Post-Heart Transplant in Patients Developing Allosensitization During Left Ventricular Assist Device Support (LVAD) (2014) (0)
Donor-Derived Cell-Free DNA in Cancer Survivors Following Heart Transplantation (2023) (0)
Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures at Incremental LVAD Speeds is a Poor Prognostic Factor Following LVAD Implantation (2018) (0)
The Effect of Preservation Modality on Myocardial Injury - A Single Blinded Study (2023) (0)
Decoupling between Pulmonary Artery and Wedge Pressure is Associated with Hemocompatibility-Related Adverse Events Following LVAD Implantation (2019) (0)
Effect of CMV Viremia on HeartCare (2022) (0)
(127) - Advantage of Bridge to Transplantation with Subclavian Intra-Aortic Balloon Pump Compared to Left Ventricular Assist Device Support (2017) (0)
Visually Estimated Coronary Artery Calcium is an Independent Prognostic Marker Following Heart Transplantation (2023) (0)
Characteristics and Outcomes of Multiple Cardiac Re-Transplant Recipients (2023) (0)
Enhanced Thrombin Formation in Patients with Implanted LVADs Experiencing GI and Other Bleeding: Insights from the Multi-center PREVENT Study (2018) (0)
Invasive Hemodynamics in Severely Obese Patients Following Continuous-Flow Left Ventricular Assist Device Implantation (2015) (0)
Five-Year Survival and Incidence of Adverse Events in Patients Implanted with HeartMate 3 Left Ventricular Assist Device at a High Volume Center (2023) (0)
Prevalence of BK Virus Infection in a Large Heart Transplant Population. (2020) (0)
IMPACT OF PREOPERATIVE LYMPHOPENIA ON OUTCOMES AFTER HEART TRANSPLANT (2021) (0)
A Clinical Study to Evaluate Ambulatory Counterpulsation for the Treatment of Advanced Heart Failure: A Feasibility Study. (2020) (0)
Abstract 16514: Screening for Outflow Cannula Malfunction of Left Ventricular Assist Devices Using Doppler Echocardiography: Establishing New Reference Values (2015) (0)
Heartmate 3 Implantation in Cancer Survivors with Advanced Heart Failure. (2020) (0)
Initial Post Approval Performance of the Heartware LVAD as Bridge to Transplantation: An Analysis of the UNOS Database (2014) (0)
Abstract 15886: When the Giant is Hidden but Not Dormant (2020) (0)
Abstract 18438: Long Term Left Ventricular Assist Device as Bridge to Heart Transplantation -- is it Really a Bridge? (2010) (0)
Reverse Remodeling Following Ambulatory Counterpulsation (2018) (0)
A cold taken to heart. (2015) (0)
Elevated Serum C-reactive Protein (CRP) Level Predicts Increased Post-Implant Mortality in Patients Undergoing HeartMate 3 LVAD Implantation. (2020) (0)
(1080) – Noninvasive Assessment of Lung Fluid Percentage in Patients with Left Ventricular Assist Devices (2017) (0)
Ambulatory Counterpulsation with a Minimally Invasive Circulatory Assist Device - Expanding Indications and Extending Support (2018) (0)
1108-116 Cardiac power output is the only independent hemodynamic predictor of outcome in acute heart failure (2004) (0)
Donor-Derived Cell-Free Dna in Heart Transplant Recipients with Microvascular Cardiac Allograft Vasculopathy (2023) (0)
Contemporary Outcomes for Cardiogenic Shock Patients Bridged to Advanced Heart Therapies with Temporary Mechanical Circulatory Support (2021) (0)
Abstract 19648: Exposure to Ionized Medical Radiation after Heart Transplant is Associated with Higher Risk of Malignancies (2012) (0)
76 Pro‐BNP level in patients with persistent lone atrial fibrillation before and after successful electrical cardioversion (2005) (0)
Pulmonary Effective Arterial Elastance and Pulmonary Artery Capacitance after Left Ventricular Assist Device Implantation is Associated with Hemocompatibility-Related Adverse Events (2019) (0)
585 Aspergillus Infection after Heart Transplantation: Risk Factors, Clinical Course and Outcomes (2011) (0)
Troponin Assessment in Heart Failure With Preserved Ejection Fraction: Time to Get With the Guidelines. (2017) (0)
ANGIOPOIETIN-2 MEDIATES ABNORMAL ANGIOGENESIS AND NON-SURGICAL BLEEDING IN PATIENTS WITH CONTINUOUS-FLOW LEFT VENTRICULAR ASSIST DEVICES (2016) (0)
Elevated Rho Kinase (ROCK) Activity Correlates with Acute Rejection in Heart Transplant Recipients (2016) (0)
MOLECULAR MECHANISM OF THE ASSOCIATION BETWEEN ATRIAL FIBRILLATION AND HEART FAILURE INCLUDES ENERGY METABOLIC DYSREGULATION Molecular Mechanisms of the Association between Atrial Fibrillation and Heart Failure. (2020) (0)
Abstract 19140: Prediction of Inotrope Initiation in Patients With Advanced Heart Failure (2013) (0)
(149) - Hemocompatibility Related Outcomes in the Multicenter Study of Maglev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with Heartmate 3 (Momentum 3) Pivotal Trial (2017) (0)
Effect of Mycophenolate Mofetil Dosing on 6-month Risk of Acute Cellular Rejection, Leukopenia and CMV Viremia in Heart Transplant (2021) (0)
The Indication for Short Term Ventricular Assist Device Placement Influences Survival (2010) (0)
Predictors of Hemodynamic Success in Advanced CHF Patients Supported by Ambulatory Counterpulsation (2018) (0)
Improvement in Coronary Allograft Vasculopathy Following Treatment with a Regimen Including Extracorporeal Photophoresis in a Heart Transplant Recipient (2022) (0)
Cystatin C Versus Creatinine-Based Assessment Of Kidney Function In Patients With Heart Failure And Reduced Ejection Fraction: Insights From PARADIGM-HF (2023) (0)
Inflow or Outflow Obstruction Requiring Surgical Corrections Late after HeartMate 3 Left Ventricular Assist Device Insertion. (2020) (0)
166 High Transpulmonary Gradient Obtained at the Time of LVAD Implantation Is Associated with Worse Long Term 1 Year Survival after Cardiac Transplantation (2012) (0)
Abstract 3661: Equal Success, but Shorter Length of Stay, With Axial Versus Pulsatile Flow Left Ventricular Assist Devices (LVAD) as Bridge to Cardiac Transplantation (BTT): The Columbia Presbyterian Experience (2009) (0)
Neurohormonal Blockade During Left Ventricular Assist Device Support. (2020) (0)
537 Cardiac power output is the best in‐depended hemodynamic predictor of outcome in acute heart failure (2004) (0)
Continuous Monitoring of Blood Pressure Using a Wrist-Worn Cuffless Device. (2022) (0)
Malnutrition is Associated with Gut Dysbiosis and Perioperative Infections in LVAD Patients (2021) (0)
Ratio of Systolic Blood Pressure to Pulmonary Capillary Wedge Pressure Ratio: A Novel Prognostic Marker in Chronic Heart Failure (2019) (0)
Echocardiographic ejection fraction in patients with acute heart failure: weak correlations with cardiac contractility and short-term outcome (2004) (0)
Long-Term Burden of Hemocompatibility Related Adverse Events in the MOMENTUM 3 Trial: Final Analysis of the 1028 Patient Cohort (2019) (0)
556 Echocardiographic ejection fraction in patients with acute heart failure: weak correlations with cardiac contractility and short-term outcome (2004) (0)
IMPACT OF THE REVERSAL OF ELEVATED PULMONARY VASCULAR RESISTANCE WITH LEFT VENTRICULAR ASSIST DEVICE OR CHRONIC VASODILATORS ON POST HEART TRANSPLANT CLINICAL OUTCOMES (2020) (0)
026 - Cardiac Allograft Vasculopathy Following Orthotopic Heart Transplant Carries a High Risk of Malignant Arrhythmias (2017) (0)
The impact of pre-existing hematologic disorders on morbidity and mortality following heart transplantation: Focus on early graft dysfunction. (2023) (0)
Pre LVAD CPET as Predictor of INTERMACS Profile and Early Outcomes Post LVAD. (2020) (0)
SCAI Shock Classification to Predict Outcomes of Venoarterial Extracorporeal Membrane Oxygenation (2021) (0)
217 Risk-Stratification of Heart Transplant (HTX) Candidates with Advanced Liver Dysfunction (2011) (0)
Abstract 18940: Application of the HeartMateII Risk Score in Patients With Continuous Flow Left Ventricular Assist Devices (2013) (0)
Sex differences in patients undergoing heart transplantation and LVAD therapy (2022) (0)
Heart Transplantation in Patients with Active Prostate Cancer; Are We Denying a Life Saving Therapy Due to an Indolent Tumor? (2018) (0)
Prediction of Mortality in Decompensated Heart Failure by Invasive Hemodynamics Compared to Clinical Assessment (2018) (0)
Comparison of Two Commercially Available Donor-Derived Cell-Free DNA Assays for Surveillance of Rejection in Heart Transplant Recipients (2023) (0)
Assessment of Ventricular Remodeling Post-LVAD with 3D Echocardiography and Surface Analysis (2016) (0)
Association of Sarcopenia and Gut Microbiome in HF, LVAD and Heart Transplant (2023) (0)
Sex Related Differences in Patients with Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation. (2020) (0)
(890) - Building a More Cost-Efficient ECLS Team by Inviting Everyone to the Table (2017) (0)
Incidence and Treatment of Arterial Hypertension After Heart Transplantation (2022) (0)
584 Pneumonia in the First Year Post-Cardiac Transplant Is Common and Associated with Reduced Long Term Survival (2011) (0)
Effects of Surgical Left Ventricular Vent in Patients with Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation (2021) (0)
Prognostic Implications and Characteristics of Low dd-cfDNA Results in Heart Transplant Patients with Biopsy Proven Rejection (2022) (0)
TCT-122 Use of the Impella 5.0 circulatory support device for bridge to decision during acute decompensation of advanced heart failure. (2016) (0)
Donor-Derived Cell-Free DNA in Heart Transplant Recipients with a History of Congenital Heart Disease (2023) (0)
100 - Impact of Heart Failure Etiology on Ventricular Unloading in Patients Supported with Left Ventricular Assist Devices (LVADs) (2017) (0)
Concordance between Coronary Artery Calcium and Coronary Angiography in the Detection of Cardiac Allograft Vasculopathy in Post Heart Transplant Patients. (2020) (0)
Estimation of Pulmonary Capillary Wedge Pressure from the HVAD Waveform and Its Prognostic Implications (2019) (0)
Use of Veno-Arterial Extracorporeal Life Support (VA ECLS) in Awake Patients in Refractory Cardiogenic Shock (2022) (0)
Non-Invasive Estimation of Pulse Pressure in HeartMate 3 Patients (2021) (0)
(598) - The Impact of Race on Hemodynamics and Heart Transplant Outcomes (2017) (0)
(1048) – Increased Post-Operative Mortality in Patients Undergoing Coronary Artery Bypass Grafting During Left Ventricular Assist Device Implantation (2017) (0)
Interventricular Interactions and Right Ventricular Function in LVAD Recipients: Insights from Pressure Volume Analyses (2022) (0)
The impact of pre‐transplant weight loss on survival following cardiac transplantation (2022) (0)
Correction to: A subcostal approach is favorable compared to sternotomy for left ventricular assist device exchange (2020) (0)
The Utility of Televisits in Patients with a Left Ventricular Assist Device (2021) (0)
Development and Validation of a Personalized Risk Score for Prediction of Patient-Specific Clinical Experiences with HeartMate 3 LVAD Implantation: An Analysis from the MOMENTUM 3 Trial Portfolio (2022) (0)
Abstract 13864: Bridging Cardiogenic Shock Patients with Short Term Ventricular Support at a Community Hospital to Long Term Ventricular Support at a Tertiary Hospital - Feasibility and Outcome. (2011) (0)
Atrial Arrhythmia in Hospitalized Patients with COVID-19 (2020) (0)
Commentary: A pandemic blueprint for planning your act and acting your plan (2020) (0)
Sex Differences in Myocardial Flow Reserve by Positron Emission Tomography in Heart Transplant Recipients. (2020) (0)
(306) - Incidence and Risk Factors of Late Bleeding in Patients Enrolled in the PREVENT Study (2017) (0)
Recurrent outflow graft compression of HeartMate3: When the left ventricular assist device sticks to the rib (2022) (0)
The Incidence and Etiology of Gastrointestinal Bleeding in Patients Supported by the HeartMate II Continuous Flow Left Ventricular Assist Device: 1094 (2011) (0)
HeartMate II to HVAD Device Exchange: What Can We Learn? (2015) (0)
The Biological Response to Ventricular Unloading (2020) (0)
Change in Mitral Valve Geometry after Left Ventricular Assist Device Implantation in Patients with Functional Mitral Regurgitation. (2020) (0)
INCREASED INSULIN SENSITIVITY IN ADVANCED HEART FAILURE PATIENTS TREATED WITH LEFT VENTRICULAR ASSIST DEVICE (2010) (0)
Abstract 14828: Comparison of Expression Profiling of the Vascular Endothelium in Patients With Heart Failure and in Healthy Subjects Using a Novel Methodology: Human Endothelial Sampling Coupled With Microarray Analysis (2013) (0)
Longitudinal Trends in Hemodynamics Following Left Ventricular Assist Device Implantation (2019) (0)
Clinical Utility of Donor Derived Cell-Free DNA in the Multiorgan Transplantation (2023) (0)
Comorbidities and Biomarkers Vary between United States and Japanese LVAD Patients (2019) (0)
Life During Long Term LVAD Support (2018) (0)
The effect of bosentan on endothelial function in patients with congestive heart failure (2005) (0)
Comparing Long-Term Survival and Readmissions Between Heartmate 3 and Heart Transplant as Primary Treatment for Advanced Heart Failure (2023) (0)
Long-Term Outcomes for Pediatric HT Patients Transitioning to Adult Care (2022) (0)
Diffuse Ventricular Hematoma after Heart Transplant and Repeated Myocardial Instrumentation (2017) (0)
Aortic Insufficiency Following Heartmate 3 Implant in Patients on Temporary Mechanical Circulatory Support (2021) (0)
[ST myocardial infarction with spontaneous coronary reperfusion]. (2006) (0)
Hemodynamic variables (cardiac power) and their changes during 6 hours are the strongest predictors of short-term outcome in acute heart failure (2004) (0)
Stromal-Derived Factor-1 (SDF-1) Expression is Downregulated After Chronic Continuous Flow Left Ventricular Assist Device (CF-LVAD) Support (2014) (0)
Three-Fold Increase in Bleeding Rate in LVAD Patients Bridged with Enoxaparin for Sub-Therapeutic INR (2016) (0)
Insights from a clinical heart valve centre: characteristics and management of functional mitral regurgitation (2022) (0)
THE HEMODYNAMIC EFFECTS OF INTRAVENOUS MILRINONE THERAPY IN HEART FAILURE WITH REDUCED EJECTION FRACTION PATIENTS ON BETA-BLOCKERS (2018) (0)
The Effect of Pre-Transplant Mechanical Circulatory Support Devices on the Post-Transplant dd-cfDNA and GEP in Heart Transplantation. (2020) (0)
Outcomes of treatment for deep left ventricular assist device infection. (2022) (0)
High Prevalence of BK Virus in Heart Transplant Patients and Effect on Outcomes (2018) (0)
Anatomical and Hemodynamic Response of the Right Ventricle During Increases in Left Ventricular Assist Device Speed (2015) (0)
Using INTERMACS(IM) to Establish Objective Performance Criteria (OPC) for Clinical Trials in “Less Sick” Advanced CHF Patients: An Analysis of the STS IM Database (2019) (0)
Troponin Increase in Acute Heart Failure – A Marker of Ischemia, a Measure of Severity or Both? (2006) (0)
Extrapulmonary manifestations of COVID-19 (2020) (0)
Advanced Heart Failure Therapies in a High Risk Urban Population (2016) (0)
Abstract 13576: Concomitant Valve Intervention During Left Ventricular Assist Device Implantation Improves Mid-term Hemodynamics and Survival (2015) (0)
Elevated Outpatient C-Reactive Protein Independently Predicts All-Cause Mortality in LVAD Recipients. (2020) (0)
The Hemodynamic Effects of Milrinone in the Beta-Blocker Era (2016) (0)
(462) - Impact of Cardiac Resynchronization Therapy (CRT) on Invasive Hemodynamics and Echocardiographic Parameters in Patients with Implanted Left Ventricular Assist Devices (LVADs) (2017) (0)
Surgical Device Exchange is Favorable to Treat Device Thrombosis Compared to Medical Therapy (2019) (0)
Comparison of Hemocompatibility-Related Adverse Events in HVAD versus HeartMate II Device (2018) (0)
Managing Contemporary AMR with a 4-Tiered Treatment Protocol: A Single-Center Experience (2022) (0)
(1068) - The Hemodynamic Effects of Concomitant Tricuspid Valve Repair and Left Ventricular Assist Device Implantation (2017) (0)
Modalities of Left Ventricular Assist Device Optimization (2019) (0)
Financial Impact of One Year of Advanced Heart Failure Therapies to a Hospital System (2018) (0)
341 - Clinical Significance of Pericardial Effusions Post OHT (2017) (0)
Incidence of Deep Venous Thrombosis and its Impact on Outcomes after Heart Transplantation (2021) (0)
Association of Angiopoetin-2 and TNF-α With Bleeding During Left Ventricular Assist Device Support: Analysis from the PREVENT Biorepository. (2023) (0)
Does Lateral Approach Preserve Better Right Ventricular Function after Left Ventricular Assist Device Insertion? (2023) (0)
Donor-Derived Cell-Free DNA in Heart Transplant Recipients Bridged with Left Ventricular Assist Device (2023) (0)
Effect of Recipient Race on Quality of Donors Allocated to Heart Transplant Recipients (2019) (0)
Clinical Outcomes in Patients Receiving Simultaneous Heart and Abdominal Organ Transplantation (2015) (0)
The Impact of Aspirin Dose on Hemocompatibility-Related Adverse Events during HeartMate 3 Support - An Analysis from the MOMENTUM 3 Trial. (2020) (0)
654 Outcome of Patients with Postcardiotomy Shock Requiring Ventricular Assist Device Support Remains Poor (2011) (0)
Long Term Survival in Continuous Flow Left Ventricular Assist Devices (2015) (0)
Hyponatremia in Acute Heart Failure – A Marker of Hyperglycemia and Reduced Renal Perfusion? (2006) (0)
Isolated Microvascular Cardiac Allograft Vasculopathy is Associated with an Increased Risk of Death or Retransplantation (2023) (0)
Ischemic Cardiomyopathy is Associated with Increased Hemocompatibility Related Adverse Events Compared to Non-Ischemic Cardiomyopathy in LVAD Patients (2019) (0)
3D echocardiographic optimization of residual native myocardial function in patients with left ventricular assist devices (2017) (0)
Impact of Long-Term Donor Derived Cell Free DNA Variability on Clinical Events Following Heart Transplantation (2023) (0)
Integrating Personalized Risk Scores in Decision Making About Left Ventricular Assist Device (LVAD) Therapy: Clinician and Patient Perspectives (2022) (0)
The Impact Of Preexisting Hematologic Disorders On Morbidity And Mortality Following Heart Transplantation (2023) (0)
The Impact of Preoperative Weight Loss on Survival Following Cardiac Transplantation (2022) (0)
Abstract 18846: Heart Rate Reserve, a Prognostic Marker for Heart Failure Hospitalizations and Adverse Outcomes (2015) (0)
Incidence and Clinical Significance of Hyperkalemia Following Heart Transplantation. (2020) (0)
Deep vein thrombosis and pulmonary embolism after heart transplantation (2022) (0)
The Utilization of Marginal Donors for Cardiac Re-Transplantation (2022) (0)
Serum Cystatin C as a Predictor of Early Outcomes and Long-Term Mortality in Contemporary LVAD Patients. (2020) (0)
Prognostication of Residual Mitral Regurgitation or Aortic Insufficiency after Invasive Hemodynamic Ramp Optimization. (2020) (0)
国際交流実績報告 Circulation : Heart Failure : Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device (2019) (0)
Lower Pulmonary Artery Pulsatility Index after Left Ventricular Assist Device Implantation is Associated with Worse Heart Failure Free Survival (2019) (0)
Global Myocardial Viability by Thallium-201 Redistribution Imaging Can Predict Successful Weaning from Short Term Mechanical Support (2014) (0)
Sex-Based Outcomes After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device (2022) (0)
The Impact of Aortic Valve Opening Status on Bleeding and Thrombotic Risk in Patients with CF-LVAD (2014) (0)
The Effect of Anticoagulation on Bleeding and Thrombotic Events during Extracorporeal Membrane Oxygenation Support for Postcardiotomy Shock. (2020) (0)
The Utility and Characteristics of Cardiovascular Magnetic Resonance Imaging in Suspected Chronic Allograft Rejection (2023) (0)
Abstract 15758: Peak Oxygen Consumption Does Not Depend on Aortic Valve Opening During Exercise in Patients with a Continuous Flow Left Ventricular Assist Device (2011) (0)
Trends in Serum Lactate Dehydrogenase During HeartMate II Left Ventricular Assist Device Support and Its Relation to Clinical Outcomes: Insights from the PREVENT Study (2017) (0)
Provider Perspectives on Advance Directives in Patients with Left Ventricular Assist Devices (2019) (0)
793 Addition of Mitral Valve Repair to Left Ventricular Assist Device Implantation (2012) (0)
35 Predictors of Right Ventricular Assist Device Following Left Ventricular Assist Device Implantation: An Assessment of Scoring Systems (2011) (0)
Response by Mehra et al to Letter Regarding Article, "Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure". (2017) (0)
Abstract 17120: Association of Endotoxemia and Endothelin-1 With Development of Cardiac Allograft Vasculopathy After Heart Transplantation (2020) (0)
(1052) - Absence of Valvular Disease Following Left Ventricular Assist Device Implantation Is Associated with Improved Midterm Survival (2017) (0)
Should We Be Comforted by a “Negative” Endomyocardial Biopsy? Risk of Future Events with Donor Derived Cell Free DNA in the Setting of Histologic Quiescence (2022) (0)
C-reactive Protein Levels Predict Right Ventricular Failure and Mortality in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Assist Device Implantation: An INTERMACS Analysis. (2020) (0)
Impact of Steroid Withdrawal on Gene Expression Profiling, Donor Derived Cell-Free DNA, and Clinical Outcomes in the SHORE Registry (2023) (0)
Cystatin C- vs. Creatinine- Based Assessment of Renal Function in Patients Admitted with Heart Failure: Insights from DOSE, ROSE and CARRESS-HF (2021) (0)
Impact of Preoperative Atrial Fibrillation on Patients with the HeartMate 3. (2020) (0)
Abstract 20054: Myocardial Expression and Circulating Serum Levels of the Extracellular Matrix Markers MMP-2, MMP-9 and Osteopontin in Patients with Advanced Heart Failure Undergoing Ventricular Assist Device Placement (2010) (0)
INCREASED TUMOR NECROSIS FACTOR-A LEVELS IN PATIENTS WITH CONTINUOUS-FLOW LEFT VENTRICULAR ASSIST DEVICES MEDIATE VASCULAR INSTABILITY AND ARE ASSOCIATED WITH HIGHER NON-SURGICAL BLEEDING (2017) (0)
The Association of Renal Dysfunction with Gut Dysbiosis in Heart Failure, LVAD and Heart Transplant Patients - A Mediation Analysis (2021) (0)
Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation (2022) (0)
Abstract 16687: The Incidence and Etiology of GI Bleeding in Patients Supported by Continuous Flow Left Ventricular Assist Device (2011) (0)
Impact of Time Post-Heart Transplant on Myocardial Flow Reserve and Outcomes. (2020) (0)
Similar Pressure and Volume Unloading With Different Geometrical Changes Between HVAD and HMII Detected During Hemodynamics 3D Echo Ramp Studies (2015) (0)
Early Normalization of Hemodynamics After Heart Transplantation Does Not Correlate With Better One-Year Survival (2016) (0)
What is the Role of Angiogenesis Markers in Cardiac Allograft Vasculopathy Following Heart Transplantation? (2019) (0)
1008-191 Statin therapy is associated with a 67 percent reduction in mortality in patients with severe chronic heart failure: Results from the placebo arm of the ENABLE study (2004) (0)
The Effects of Hemodynamic Unloading in African Americans Implanted with Left Ventricular Assist Devices (2019) (0)
Heart Transplant Under Sizing is Associated with Adverse Early Hemodynamics but Does Not Affect Survival (2019) (0)
MINI-FOCUS ISSUE : MECHANICAL CIRCULATORY SUPPORT : OPPORTUNITIES AND CHALLENGES Identi fi cation and Management of Pump Thrombus in the HeartWare Left Ventricular Assist Device System A Novel Approach Using Log File Analysis (2015) (0)
A “Negative” Endomyocardial Biopsy after an Elevated Donor-Derived Cell Free DNA is Associated with Worse Survival after Heart Transplant (2023) (0)
Predictors of One-Year Outcome in Patients Undergoing Cardiac Re-Transplantation: Machine Learning Analysis (2022) (0)
Hemodynamic Parameters That Predict Success with an Ambulatory Counterpulsation Heart Assist System in Advanced Congestive Heart Failure (2019) (0)
Causes and Temporal Patterns of Hospital Readmissions after Implantation of the HeartMate 3 Left Ventricular Assist Device: A Comparison with HeartMate II (2021) (0)
Vascular Reactivity Analysis in Patients with Continuous Flow Left Ventricular Assist Devices (CF-LVADs) - The Role of Endothelial Function in Continuous Flow Physiology (2016) (0)
Effect of mechanical unloading on genome-wide DNA methylation profile of the failing human heart (2023) (0)
Long Term Left Ventricular Assist Device as Bridge to Heart Transplantation: De Facto Destination Therapy in Many? (2010) (0)
The Hemodynamic Effects of Pump Speed Adjustments in Patients with Heartmate 3 Left Ventricular Assist Device (2023) (0)
Association of Donor Age and Plasma Donor-Derived Cell-Free DNA Levels with CAV Development after Heart Transplant: SHORE Preliminary Data (2021) (0)
The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial- ﬂ ow left ventricular assist device (2017) (0)
Safety and Efficacy of Pre Transplant Desensitization of Patients Supported by CF-LVADs (2014) (0)
Donor-Derived Cell-Free DNA in Heart Transplant Recipients with Coronary Allograft Vasculopathy (2023) (0)
Functional Status, Quality of Life and Ventricular Tachyarrhythmias Improve with Right Ventricular Pacing Compared to Biventricular Pacing in LVAD Patients (2019) (0)
Cases of Surgical Intervention for Outflow Graft Obstruction Due to Accumulation of Biodebris Following HeartMate 3 Implantation (2022) (0)
Optimal Cannula Positioning of Heart Mate 3 Left Ventricular Assist Device. (2020) (0)
Interventricular Interactions in LVAD Recipients: Insights from PV Loop Analysis (2023) (0)
The Effect of Temperature Control Versus Icebox Preservation on Post Heart Transplant Outcome (2023) (0)
First Report of the Transmedics Organ Care System Heart Perfusion Registry. A Multi-Institutional Outcomes Analysis (2023) (0)
LVHNET: DETECTING CARDIAC STRUCTURAL ABNORMALITIES FROM CHEST X-RAYS USING CONVOLUTIONAL NEURAL NETWORKS (2021) (0)
How can we better inform our patients about post‐heart transplantation survival? A conditional survival analysis (2021) (0)
Geographic Variation Exists in Heart Transplantation for Status One and Two Patients after the 2018 Heart Allocation Policy Change (2023) (0)
Predictors of Hemodynamic Stabilization Following Intra-Aortic Balloon Pump Implantation for Cardiogenic Shock (2017) (0)
Letermovir for cytomegalovirus prophylaxis in high‐risk heart transplant recipients (2022) (0)
421 Elevations in Donor Troponin Levels Do Not Predict Worse Outcomes Following Orthotopic Heart Transplant (2012) (0)
Allosensitization in Heart Transplantation: The Importance of a Comprehensive Approach (2021) (0)
HeartNet™ in an explanted heart of a Jehovah's Witness (2018) (0)
Renal Function is Similar in LVAD Patients Regardless of Hemodynamic Status (2018) (0)
Pulsatility and Flow Patterns across Macro- and Microcirculatory Arteries of Continuous-Flow Left Ventricular Assist Device Patients. (2023) (0)
A Signal in the Noise: Noninvasive Acoustical Evaluation of Continuous Flow Left Ventricular Assist Device (2021) (0)
Increased Rate of Pump Thrombosis and Cardioembolic Events Following Ventricular Tachycardia Ablation in Patients Supported With Left Ventricular Assist Devices. (2020) (0)
(902) - Acute Cellular Rejection in Heart Transplant Recipients May Not Be Acute After All (2017) (0)
Similar Post-Heart Transplant Outcomes with Undersized or Oversized Donors When Left Ventricular End Diastolic Dimension (LVEDD) Is within Range (2016) (0)
Successful Use of Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridging Strategy in INTERMACS 1 Patients Undergoing HeartMate 3 LVAD Implantation. (2020) (0)
Association between Area Deprivation Index and Listing for Heart Transplantation at an Academic Medical Center (2021) (0)
VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION IN A YOUNG MALE WITH MULTISYSTEM INFLAMMATORY SYNDROME FOLLOWING COVID-19 INFECTION (2023) (0)
Variability Across Implanting Centers in Short and Long-Term Mortality and Adverse Events in Patients on HeartMate 3 Support: A Momentum 3 Secondary Analysis (2022) (0)
Percutaneous Subclavian Intra-Aortic Balloon Pump: An Evolving Technique (2017) (0)
Atrial Fibrillation in Patients Supported by Continuous-Flow Left Ventricular Assist Device (2014) (0)
Catheter Ablation of Ventricular Arrhythmias in Patients Supported by Left Ventricular Assist Device (2013) (0)
Strong Correlation Between Alere Home INR and Core Lab INR in Patients Supported with CF-LVAD (2014) (0)
Impaired Stress-Induced Free Fatty Acid and Glucose Release in Congestive Heart Failure Patients With Insulin Resistance: A State of Metabolic Incompetence (2010) (0)
Takotsubo Cardiomyopathy and Resultant Cardiogenic Shock After Mitral Valve Repair (2011) (0)
Clinical Characteristics and Outcomes of Cancer Survivors Undergoing Heart Transplantation (2021) (0)
Right Heart Function Worsens in LVAD Patients with Decoupling between Pulmonary Artery and Wedge Pressures (2019) (0)
Relationship Between Absolute Quantification of Donor-Derived Cell-Free DNA and Donor-Derived Cell-Free DNA Fraction for Detection of Allograft Rejection in Heart Transplant Patients (2023) (0)
Frequency of Unplanned Hospital Readmissions and Impact on Survival in HeartMate3 (HM3) Patients (2022) (0)
Clinical Profile of Patients with Late Stroke after Left Ventricular Assist Device Implantation (2018) (0)
HeartMate II Risk Score (HMRS) and MELD-Xi Scores Do Not Predict Mortality in HeartMate 3 LVAD Patients. (2020) (0)
Home Inotropes in Patients with Left Ventricular Assist Devices (2016) (0)
Decoupling between Diastolic Pulmonary Artery Pressure and Pulmonary Artery Wedge Pressure at Incremental LVAD speeds is Associated with Worse Prognosis following LVAD Implantation (2018) (0)
Association Between Tacrolimus Concentration/Dose Ratio and Renal Function Following Cardiac Transplant (2018) (0)
Patients With Visuospatial Constructional Deficits May Successfully Manage LVADs (2015) (0)
Nurse Practitioners Provide Safe and Effective Care to Patients in the First Year after Cardiac Transplantation in a Combined Nurse Practitioner-Physician Clinic (2016) (0)
74 Pre- and Post-Operative Risk Factors Associated with Neurological Complications in Patients Supported by Ventricular Assist Device (2011) (0)
Utilization of Mechanical Circulatory Support Devices and Impact on Outcomes in the New Heart Allocation System: An Analysis of the UNOS Registry. (2020) (0)
Estimation of Central Venous Pressure by Pacemaker Lead Impedances in LVAD Patients (2018) (0)
Longitudinal Rho-Associated Kinase (ROCK) Activity Correlates with Rejection in Heart Transplant Recipients (2017) (0)
(1342) – A New Cannulation Technique for Ambulatory Percutaneous RVAD (2017) (0)
Sex-Based Outcomes of Heart Re-Transplantation: Analysis from UNOS Database (2021) (0)
The Effect of Pre-Existing Hypercoagulable Disorders on Outcomes in Patients with LVADs (2017) (0)
Increasing Use of Mechanical Circulatory Support as a Bridge to Cardiac Retransplantation (2014) (0)
Impact of Race and Ethnicity on Readmissions After HeartMate 3 (HM3) Implantation (2022) (0)
Cystatin C- versus Creatinine-Based Assessment of Kidney Function in Advanced Heart Failure: Insights from REVIVAL (2022) (0)
Consequences of functional mitral regurgitation and atrial fibrillation in patients with left ventricular assist devices. (2020) (0)
Comparison of Risk Models in the Prediction of 30-Day Mortality in Acute Myocardial Infarction–Associated Cardiogenic Shock (2022) (0)
(939) – Increased Risk of Rejection and Mortality in Heart Transplant Patients Receiving Granulocyte-Colony Stimulating Factor (2017) (0)
Severe Myocardial Necrosis and Acute Allograft Failure from Fulminant Clostridium Perfringens Sepsis (2023) (0)
Abstract 14749: Use of Rho-associated coiled-coil forming kinase (ROCK) Activity for Rejection Surveillance in Heart Transplant Recipients (2014) (0)
Abstract 10882: Acute Venous Congestion Induces Local Release of Proinflammatory Cytokines and Endothelial Activation in Humans (2011) (0)
Abstract 14309: Beta Blocker Cessation Does Not Restore Chronotropic Response in Patients With Advanced Heart Failure (2011) (0)
(226) – Reduced PF4 and C6orf25 Gene Copies Prior to LVAD in Patients with Thromboembolic Events (2017) (0)
Longitudinal Trend of Tricuspid Regurgitation Following Left Ventricular Assist Device Implantation (2019) (0)
Abstract 17072: Discordance Between Lactic Acid Elevation and Invasive Hemodynamics in Decompensated Heart Failure (2018) (0)
Against All Odds - Transplanting Against 100% Reactive Antibodies and the Role of Non-Invasive Monitoring (2023) (0)
8: Development of Aortic Insufficiency in Patients Supported with a HeartMate II Left Ventricular Assist Device (LVAD) (2010) (0)
Abstract 18963: Over-expression of Angiopoietin-2 in Human Patients With Continuous-flow Left Ventricular Assist Devices Induces Abnormal Angiogenesis and Predicts Gastrointestinal Bleeding Events (2015) (0)
(463) - Right Ventricular Pacing Improves Functional Status and Quality of Life Compared to Biventricular Pacing in Left Ventricular Assist Device Patients (2017) (0)
Abstract 16747: The Artificial Pulse of the HeartMate3 LVAD Alters Mean Arterial Pressure Calculation, and the Relationship Between Arterial Pulse Pressure and Pulsatility Index (2020) (0)
Combined heart and liver transplantation in a patient supported by left ventricular assist device (LVAD) with propionic acidemia. (2023) (0)
Clinical Impact of Hematoma Expansion in Left Ventricular Assist Device Patients. (2020) (0)
Acute Right Ventricular Dimensional Change Predicts Outcomes in Patients with Heartmate 3 (2023) (0)
Impact of Donor Characteristics on AlloSure Scores (2022) (0)
Oral Milrinone for the Treatment of Right Ventricular Failure in LVAD Patients (2019) (0)
Post-Cardiac Transplant Survival of Patients Supported by the Heartmate 3 Devices: A UNOS Analysis (2019) (0)
[The approach to a patient with hypokalemia]. (2001) (0)
Chronic intermittent intravenous immunoglobulin in heart transplant recipients with elevated donor‐specific antibody levels (2021) (0)
The Clinical Impact of Ventricular Arrhythmias Following Continuous Flow Left Ventricular Assist Device Implantation (2013) (0)
Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD (2022) (0)
Abstract 19043: Left Atrial Structural Remodeling With Ventricular Assist Device (2016) (0)
Early post-transplant leukopenia in heart transplant recipients and its impact on outcomes. (2023) (0)
Ability to Obtain Blood Pressure Readings By Standard Automated Blood Pressure Monitor Helps Interpreting the Relationship Between Doppler Blood Pressure to Systolic Blood Pressure and Mean Arterial Pressure (2015) (0)
Psychiatric Comorbidities in Pediatric HT Patients Transitioning to Adult Care (2022) (0)
Implementation of Patient-Centered Shared Decision Making for LVAD Candidates: Year 1 Results of a Multi-Site Study. (2020) (0)
Postoperative Tolvaptan Use in Left Ventricular Assist Device Implantation Patients: The TOLVAD Study (2021) (0)
Education and Decision-Making in Patients and Caregivers Considering Left Ventricular Assist Devices (2019) (0)
Effects of ACE Inhibitors, Angiotensin Receptor Blockers and Angiotensin Receptor-Neprilysin Inhibitors on Survival Free from Gastrointestinal Bleeding in HeartMate 3 Patients - A Marginal Structural Modeling Analysis (2021) (0)
Images in Cardiovascular Medicine Ventricular Assist Device-Associated Thrombus (2011) (0)
Actual-to-Expected Advanced Heart Failure Therapy Utilization in the United States by Race/Ethnicity (2023) (0)
The Safety of a Non-Invasive Monitoring Protocol in Heart Transplant Recipients (2021) (0)
Hemolysis, Device Thrombosis, and Risk of CVA in HM II: Patients: Role of Watchful Waiting? (2015) (0)
OUTCOMES FOLLOWING TELEHEALTH VISITS DURING THE COVID-19 PANDEMIC IN AN ADVANCED HEART FAILURE PRACTICE (2021) (0)
Association between Cumulative Pre-Transplant Amiodarone Dose and Post-Transplant Outcomes after Heart Transplantation (2019) (0)
Effect of Acute b-blocker Withholding on Ventilatory Efficiency in Patients With Advanced Chronic Heart Failure (2010) (0)
Saving the patient with post-ACS cardiogenic shock. (2013) (0)
Use of Serum Cystatin C versus Creatinine for Estimation of Renal Function and Valganciclovir Dosing in Heart Transplant Recipients. (2020) (0)
Reliability of 2D Echocardiography to Identify Hemodynamically Significant Right Ventricular Failure in Patients Supported with Cf-LVAD (2016) (0)
Authors' Reply to the Comments of Joshua Fogel and Abhinav Saxena on Our Paper. (2019) (0)
Gene Expression Profiling Test (GEP) Scores and Outcomes of Heart Transplant with Prior Mechanical Circulatory Support: Results from IMAGE and CARGO II (2014) (0)
Association of Gut Bacterial Beta Glucuronidase Activity with Mycophenolate Mofetil Induced Cytopenia (2022) (0)
Comparison of Heart Replacement Therapy in Patients Over 65 Years Old (2014) (0)
Donor-Derived Cell-Free DNA Does Not Correlate with Levels of Inflammation or Angiogenesis in a Stable Post Transplant Population. (2020) (0)
Abstract 19732: Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance and Normalizes Cardiac Metabolism in Advanced Heart Failure (2010) (0)
Impact of a Novel Social Worker Psychosocial Assessment (6D-SW) on Prospective Outcomes in HeartMate 3 (HM3) Patients (2023) (0)
(1078) - The Ramp Fingerprint: LVAD Patients Have Similar Filling Pressures and Speed Change Responses at Repeat Ramp Tests (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Nir Y. Uriel?

Nir Y. Uriel is affiliated with the following schools:

University of Chicago
Columbia University